We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBarclays Regulatory News (BARC)

Share Price Information for Barclays (BARC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 204.65
Bid: 204.55
Ask: 204.65
Change: 1.95 (0.96%)
Spread: 0.10 (0.049%)
Open: 200.75
High: 205.25
Low: 198.84
Prev. Close: 202.70
BARC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

1st Quarter Results

27 Apr 2023 07:00

RNS Number : 6088X
Barclays PLC
27 April 2023
 

Barclays PLC

 

Q1 2023 Results Announcement

 

31 March 2023

 

Notes

 

The terms Barclays and Group refer to Barclays PLC together with its subsidiaries. Unless otherwise stated, the income statement analysis compares the three months ended 31 March 2023 to the corresponding three months of 2022 and balance sheet analysis as at 31 March 2023 with comparatives relating to 31 December 2022 and 31 March 2022. The abbreviations '£m' and '£bn' represent millions and thousands of millions of Pounds Sterling respectively; the abbreviations '$m' and '$bn' represent millions and thousands of millions of US Dollars respectively; and the abbreviations '€m' and '€bn' represent millions and thousands of millions of Euros respectively.

 

There are a number of key judgement areas, for example impairment calculations, which are based on models and which are subject to ongoing adjustment and modifications. Reported numbers reflect best estimates and judgements at the given point in time.

 

Relevant terms that are used in this document but are not defined under applicable regulatory guidance or International Financial Reporting Standards (IFRS) are explained in the results glossary, which can be accessed at home.barclays/investor-relations.

 

The information in this announcement, which was approved by the Board of Directors on 26 April 2023, does not comprise statutory accounts within the meaning of Section 434 of the Companies Act 2006. Statutory accounts for the year ended 31 December 2022, which contained an unmodified audit report under Section 495 of the Companies Act 2006 (which did not make any statements under Section 498 of the Companies Act 2006) will be delivered to the Registrar of Companies in accordance with Section 441 of the Companies Act 2006.

 

These results will be furnished on Form 6-K with the US Securities and Exchange Commission (SEC) as soon as practicable following their publication. Once furnished with the SEC, a copy of the Form 6-K will be available from the SEC's website at www.sec.gov.

 

Barclays is a frequent issuer in the debt capital markets and regularly meets with investors via formal road-shows and other ad hoc meetings. Consistent with its usual practice, Barclays expects that from time to time over the coming quarter it will meet with investors globally to discuss these results and other matters relating to the Group.

 

Non-IFRS performance measures

 

Barclays' management believes that the non-IFRS performance measures included in this document provide valuable information to the readers of the financial statements as they enable the reader to identify a more consistent basis for comparing the businesses' performance between financial periods and provide more detail concerning the elements of performance which the managers of these businesses are most directly able to influence or are relevant for an assessment of the Group. They also reflect an important aspect of the way in which operating targets are defined and performance is monitored by Barclays' management. However, any non-IFRS performance measures in this document are not a substitute for IFRS measures and readers should consider the IFRS measures as well. Refer to the appendix on pages 38 to 43 for further information and calculations of non-IFRS performance measures included throughout this document, and the most directly comparable IFRS measures.

 

Forward-looking statements

 

This document contains certain forward-looking statements within the meaning of Section 21E of the US Securities Exchange Act of 1934, as amended, and Section 27A of the US Securities Act of 1933, as amended, with respect to the Group. Barclays cautions readers that no forward-looking statement is a guarantee of future performance and that actual results or other financial condition or performance measures could differ materially from those contained in the forward-looking statements. Forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements sometimes use words such as 'may', 'will', 'seek', 'continue', 'aim', 'anticipate', 'target', 'projected', 'expect', 'estimate', 'intend', 'plan', 'goal', 'believe', 'achieve' or other words of similar meaning. Forward-looking statements can be made in writing but also may be made verbally by directors, officers and employees of the Group (including during management presentations) in connection with this document. Examples of forward-looking statements include, among others, statements or guidance regarding or relating to the Group's future financial position, income levels, costs, assets and liabilities, impairment charges, provisions, capital, leverage and other regulatory ratios, capital distributions (including dividend policy and share buybacks), return on tangible equity, projected levels of growth in banking and financial markets, industry trends, any commitments and targets (including environmental, social and governance (ESG) commitments and targets), business strategy, plans and objectives for future operations and other statements that are not historical or current facts. By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances. Forward-looking statements speak only as at the date on which they are made. Forward-looking statements may be affected by a number of factors, including, without limitation: changes in legislation, regulation and the interpretation thereof, changes in IFRS and other accounting standards, including practices with regard to the interpretation and application thereof and emerging and developing ESG reporting standards; the outcome of current and future legal proceedings and regulatory investigations; the policies and actions of governmental and regulatory authorities; the Group's ability along with governments and other stakeholders to measure, manage and mitigate the impacts of climate change effectively; environmental, social and geopolitical risks and incidents and similar events beyond the Group's control; the impact of competition; capital, leverage and other regulatory rules applicable to past, current and future periods; UK, US, Eurozone and global macroeconomic and business conditions, including inflation; volatility in credit and capital markets; market related risks such as changes in interest rates and foreign exchange rates; higher or lower asset valuations; changes in credit ratings of any entity within the Group or any securities issued by it; changes in counterparty risk; changes in consumer behaviour; the direct and indirect consequences of the Russia-Ukraine war on European and global macroeconomic conditions, political stability and financial markets; direct and indirect impacts of the coronavirus (COVID-19) pandemic; instability as a result of the UK's exit from the European Union (EU), the effects of the EU-UK Trade and Cooperation Agreement and any disruption that may subsequently result in the UK and globally; the risk of cyber-attacks, information or security breaches or technology failures on the Group's reputation, business or operations; the Group's ability to access funding; and the success of acquisitions, disposals and other strategic transactions. A number of these factors are beyond the Group's control. As a result, the Group's actual financial position, results, financial and non-financial metrics or performance measures or its ability to meet commitments and targets may differ materially from the statements or guidance set forth in the Group's forward-looking statements. Additional risks and factors which may impact the Group's future financial condition and performance are identified in Barclays PLC's filings with the SEC (including, without limitation, Barclays PLC's Annual Report on Form 20-F for the financial year ended 31 December 2022), which are available on the SEC's website at www.sec.gov.

 

Subject to Barclays PLC's obligations under the applicable laws and regulations of any relevant jurisdiction (including, without limitation, the UK and the US) in relation to disclosure and ongoing information, we undertake no obligation to update publicly or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

 

Performance Highlights

 

Barclays delivered a return on tangible equity (RoTE) of 15.0% and remains on track to deliver its 2023 targets, with all performance metrics in line with or ahead of guidance at Q123

 

C. S. Venkatakrishnan, Group Chief Executive, commented

"This is a strong first quarter with Group income up 11% to £7.2bn and profit before tax up 16% to £2.6bn, generating a Group RoTE of 15.0% and earnings per share (EPS) of 11.3p. All three businesses have performed well with high quality income growth and double-digit returns. The momentum across the Group allows us to maintain a robust capital position, deliver attractive returns to shareholders, and support our customers and clients through an uncertain economic environment."

 

Key financial metrics:

 

Income

Cost: income ratio

LLR

Profit before tax

Attributable profit

RoTE

EPS

LCR

Loan: deposit ratio

TNAV per share

CET1 ratio

Q123

£7.2bn

57%

52bps

£2.6bn

£1.8bn

15.0%

11.3p

163%

73%

301p

13.6%

 

Q123 Performance highlights:

 

·

Group attributable profit was £1.8bn and RoTE was 15.0%, with all operating divisions delivering double-digit returns

·

Group income was £7.2bn, up 11% year-on-year, with diverse sources of growth across the Group as well as the benefit from USD appreciation:

-

Barclays UK income increased 19% primarily driven by net interest income growth from higher rates and continued structural hedge income momentum, delivering a net interest margin (NIM) of 3.18%

-

Corporate and Investment Bank (CIB) income increased 1% to £4.0bn, representing a record Q1 income performance1. Drivers included a strong performance in Transaction banking and Global Markets, against a record prior year comparative, with lower Investment Banking income due to a reduced industry fee pool2

-

Consumer, Cards and Payments (CC&P) income increased 47% from growth in US cards balances, including the Gap portfolio acquisition3, and growth in client assets and liabilities in the Private Bank, as well as the higher rate environment

·

Group operating expenses were £4.1bn, in line with prior year, including the non-repeat of certain litigation and conduct items. Group operating expenses excluding litigation and conduct charges increased to £4.1bn (Q122: £3.6bn) reflecting the impact of business growth, inflation and USD appreciation. The Group delivered positive statutory cost: income jaws and a cost: income ratio of 57%

·

Credit impairment charges were £0.5bn, with a loan loss rate (LLR) of 52bps, within the guided range of 50-60bps, reflecting higher US cards balances and the continuing normalisation anticipated in US cards delinquencies. Coverage ratios remain strong

·

Common Equity Tier 1 (CET1) ratio of 13.6% (December 2022: 13.9%) reflected the expected reduction of an aggregate c.40bps of capital impacts in Q123 including the £0.5bn buyback announced at FY22, and seasonally higher Risk Weighted Assets (RWAs) in the Global Markets business, which supported the strong Q1 income performance

·

Tangible net asset value (TNAV) per share of 301p, increased 6p since December 2022

·

Liquidity coverage ratio (LCR) of 163% (December 2022: 165%) and Net Stable Funding Ratio (NSFR) of 139% (December 2022: 137%), well above regulatory minimum requirements

·

Loan: deposit ratio was maintained at 73% (December 2022: 73%). The Group maintains a diverse and stable deposit franchise including across wholesale and consumer as well as across different geographies

 

1

On a comparable basis, period covering 2014-Q123. Pre 2014 data was not restated following re-segmentation in 2016.

2

Data source: Dealogic for the period covering 1 January to 31 March 2023.

3

The Gap portfolio refers to the Gap Inc. US credit card portfolio.

 

Group Targets and Outlook:

 

·

Returns: targeting RoTE of greater than 10% in 2023, consistent with our medium-term target  

·

Income: diversified income streams continue to position the Group well for the current economic and market environment including higher interest rates. In 2023, Barclays UK NIM is expected to be greater than 3.20%1

·

Costs: targeting a cost: income ratio percentage in the low 60s in 2023, investing for growth whilst progressing towards the Group's medium-term target of below 60%

·

Impairment: expect an LLR of 50-60bps in 2023, based on the current macroeconomic outlook

·

Capital: expect to operate within the CET1 ratio medium-term target range of 13-14%

·

Capital returns: capital distribution policy incorporates a progressive ordinary dividend, supplemented with share buybacks as appropriate

 

1

Assumes the UK bank rate peaks at 4.25% in 2023.

 

Barclays Group results

for the three months ended

31.03.23

31.03.22

£m

£m

% Change

Barclays UK

1,961

1,649

19

Corporate and Investment Bank

3,976

3,938

1

Consumer, Cards and Payments

1,306

886

47

Barclays International

5,282

4,824

9

Head Office

(6)

23

 

Total income

7,237

6,496

11

Operating costs

(4,111)

(3,588)

(15)

Litigation and conduct

1

(523)

Total operating expenses

(4,110)

(4,111)

Other net expenses

(5)

(10)

50

Profit before impairment

3,122

2,375

31

Credit impairment charges

(524)

(141)

Profit before tax

2,598

2,234

16

Tax charge

(561)

(614)

9

Profit after tax

2,037

1,620

26

Non-controlling interests

(8)

(1)

Other equity instrument holders

(246)

(215)

(14)

Attributable profit

1,783

1,404

27

Performance measures

Return on average tangible shareholders' equity

15.0%

11.5%

Average tangible shareholders' equity (£bn)

47.6

48.8

Cost: income ratio

57%

63%

Loan loss rate (bps)

52

15

Basic earnings per share

11.3p

8.4p

Basic weighted average number of shares (m)

15,770

16,682

(5)

Period end number of shares (m)

15,701

16,762

(6)

 

As at 31.03.23

As at 31.12.22

As at 31.03.22

Balance sheet and capital management1

£bn

£bn

£bn

Loans and advances at amortised cost

403.5

398.8

371.7

Loans and advances at amortised cost impairment coverage ratio

1.4%

1.4%

1.5%

Total assets

1,539.1

1,513.7

1,496.1

Deposits at amortised cost

555.7

545.8

546.5

Tangible net asset value per share

301p

295p

294p

Common equity tier 1 ratio

13.6%

13.9%

13.8%

Common equity tier 1 capital

46.0

46.9

45.3

Risk weighted assets

338.4

336.5

328.8

UK leverage ratio

5.1%

5.3%

5.0%

UK leverage exposure

1,168.9

1,130.0

1,123.5

Average UK leverage ratio

4.8%

4.8%

4.8%

Average UK leverage exposure

1,251.3

1,281.0

1,179.4

Funding and liquidity

Group liquidity pool (£bn)

333.0

318.0

319.8

Liquidity coverage ratio

163%

165%

159%

Net stable funding ratio2

139%

137%

Loan: deposit ratio

73%

73%

68%

 

1

Refer to pages 29 to 34 for further information on how capital, RWAs and leverage are calculated.

2

Represents average of the last four spot quarter end positions.

 

Group Finance Director's Review

 

Group performance

 

·

Barclays delivered a profit before tax of £2,598m (Q122: £2,234m), RoTE of 15.0% (Q122: 11.5%) and EPS of 11.3p (Q122: 8.4p)

·

The Group has a diverse income profile across businesses and geographies including a significant presence in the US. The appreciation of average USD against GBP positively impacted income and profits and adversely impacted credit impairment charges and total operating expenses

·

Group income increased 11% to £7,237m primarily from the higher interest rate environment and continued structural hedge income momentum benefiting Barclays UK, Transaction banking and the Private Bank, the benefit of higher balances in US cards, and growth in client assets and liabilities in the Private Bank

·

Group operating expenses were stable at £4,110m (Q122: £4,111m)

-

Group operating expenses excluding litigation and conduct charges increased to £4,111m (Q122: £3,588m) reflecting the impact of business growth and inflation

-

The prior year litigation and conduct charges of £523m included charges relating to the Over-issuance of Securities in the US (Over-issuance of Securities1) and customer remediation costs relating to a legacy loan portfolio

·

Credit impairment charges were £524m (Q122: £141m) reflecting higher US cards balances, including the Gap portfolio acquisition in Q222, and the continuing normalisation anticipated in US cards delinquencies. Total coverage ratio remains strong at 1.4% (December 2022: 1.4%)

·

The effective tax rate (ETR) was 21.6% (Q122: 27.5%). The prior year included the tax charge recognised for the re-measurement of the Group's UK deferred tax assets as a result of the UK banking surcharge rate being reduced from 8% to 3%

·

Attributable profit was £1,783m (Q122: £1,404m)

·

Total assets increased to £1,539.1bn (December 2022: £1,513.7bn) driven by increased trading and client activity within Global Markets and the acquisition of Kensington Mortgage Company (KMC), partially offset by strengthening of GBP against USD since December 2022. The Group liquidity pool was further strengthened by growth in deposits and wholesale funding

·

TNAV per share increased to 301p (December 2022: 295p) as EPS of 11.3p and other reserve movements were partially offset by the 2022 full year dividend paid on 31 March 2023

 

Barclays UK

 

Barclays UK delivered a RoTE of 20.0% supported by higher interest rates and the continued investment in our transformation into a next-generation, digitised consumer bank.

·

Profit before tax increased 27% to £754m with a RoTE of 20.0% (Q122: 15.6%)

·

Total income increased 19% to £1,961m. Net interest income increased 21% to £1,618m with a NIM of 3.18% (Q122: 2.62%), continuing to build as higher interest rates and associated structural hedge benefit outweighed mortgage margin pressure. Net fee, commission and other income increased 11% to £343m partially driven by transactional income in Business Banking and UK cards

-

Personal Banking income increased 23% to £1,253m, driven by higher interest rates, partially offset by mortgage margin compression

-

Barclaycard Consumer UK income decreased 11% to £247m as higher customer spend volumes were more than offset by lower interest earning lending balances following repayments and ongoing prudent risk management

-

Business Banking income increased 31% to £461m driven by higher interest rates alongside improved transaction based revenues, partially offset by lower government scheme lending as repayments continue

·

Total operating expenses increased 9% to £1,094m from the impact of inflation with ongoing efficiency savings reinvested in digitisation to support further improvements to the cost: income ratio over time

·

Credit impairment charges were £113m (Q122: £48m), reflecting limited observed deterioration. UK cards 30 and 90 day arrears remained below pre-pandemic levels at 0.9% (Q122: 1.0%) and 0.2% (Q122: 0.3%) respectively2. The UK cards total coverage ratio was 7.7% (December 2022: 7.6%)

·

Loans and advances to customers at amortised cost increased 2% to £208.2bn primarily reflecting the acquisition of KMC

·

Customer deposits at amortised cost decreased 1% to £254.3bn. Increases in savings product balances were more than offset by reduced current account and business banking deposits, reflecting broader market trends. The loan: deposit ratio increased to 90% (December 2022: 87%)

·

RWAs increased to £74.6bn (December 2022: £73.1bn) including £0.8bn related to the acquisition of KMC

 

1

Denotes the Over-issuance of Securities under Barclays Bank PLC's (BBPLC) US shelf registration statements on Form F-3 filed with the SEC in 2018 and 2019.

2

As at 31 December 2019, UK cards 30 and 90 days arrears were 1.7% and 0.8% respectively.

 

Barclays International

 

Barclays International delivered a RoTE of 14.5%. CIB continued to support clients through a period of market volatility, with performance reflecting the benefits of income diversification and continued investment in sustainable growth. CC&P performance reflects continued investment in the business resulting in balance growth and increased income, partially offset by higher impairment charges.

·

Profit before tax increased 13% to £1,928m with a RoTE of 14.5% (Q122: 14.8%), reflecting a RoTE of 15.2% (Q122: 17.1%) in CIB and 10.5% (Q122: (1.5)%) in CC&P

·

Barclays International has a diverse income profile across businesses and geographies including a significant presence in the US. The appreciation of average USD against GBP positively impacted income and profits, and adversely impacted credit impairment charges and total operating expenses

·

Total income increased to £5,282m (Q122: £4,824m)

-

CIB income of £3,976m (Q122: £3,938m) represented the best Q1 on a comparable basis1

-

Global Markets income of £2,492m decreased 8% against a record prior year comparative. FICC income increased 9% to £1,788m, driven by a strong performance in credit. Equities income decreased 33% to £704m driven by a decline in derivatives income reflecting less volatile equity market conditions relative to prior year

 

-

Investment Banking fees decreased 7% to £603m due to the reduced fee pool2, partially offset by a strong performance in advisory representing the best Q1 performance1

 

-

Within Corporate, Transaction banking income increased 68% to £786m representing the best Q1 performance1, driven by improved margins, in the higher rate environment, in deposits. Corporate lending income decreased 24% to £95m mainly driven by costs of higher credit protection

 

-

CC&P income increased 47% to £1,306m

-

International Cards and Consumer Bank income increased 67% to £900m reflecting higher cards balances and improved margins, including the Gap portfolio acquisition in Q222

 

-

Private Bank income increased 21% to £258m, reflecting client balance growth and improved margins

 

-

Payments income increased 10% to £148m driven by merchant acquiring turnover growth

 

·

Total operating expenses decreased 2% to £2,953m and increased 18% to £2,956m excluding litigation and conduct, reflecting continued investment in the business

-

CIB total operating expenses decreased 2% to £2,199m. Operating expenses excluding litigation and conduct charges increased 15% to £2,202m driven by continued investment in talent and technology, and the impact of appreciation of average USD and inflation

-

CC&P total operating expenses decreased 3% to £754m. Operating expenses excluding litigation and conduct charges increased 29% to £754m, driven by higher investment spend to support growth, mainly in marketing and partnership costs, including the Gap portfolio acquisition, and the impact of appreciation of average USD and inflation

·

Credit impairment charges were £404m (Q122: £101m) reflecting higher balances and the continuing normalisation anticipated in US cards delinquencies

-

CIB credit impairment charges of £33m (Q122: £33m net release) were driven by single name charges partially offset by the benefit of credit protection

-

CC&P credit impairment charges increased to £371m (Q122: £134m), reflecting higher US cards balances, including the Gap portfolio, and the continuing normalisation anticipated in delinquencies. US cards 30 and 90 day arrears were 2.3% (Q122: 1.6%) and 1.2% (Q122: 0.8%) respectively. The US cards total coverage ratio was 8.9% (December 2022: 8.1%)

·

RWAs increased to £255.1bn (December 2022: £254.8bn) mainly supporting increased client and trading activity within Global Markets, partially offset by strengthening of GBP against USD since December 2022

 

Head Office

 

·

Loss before tax was £84m (Q122: £73m)

·

Total income was an expense of £6m (Q122: £23m income) with hedge accounting gains offset by treasury items. The prior year included a one-off gain of £86m from the sale and leaseback of UK data centres

·

Total operating expenses were £63m (Q122: £86m)

·

RWAs were £8.8bn (December 2022: £8.6bn)

 

1

On a comparable basis, period covering 2014-Q123. Pre 2014 data was not restated following re-segmentation in 2016.

2

Data source: Dealogic for the period covering 1 January to 31 March 2023.

 

Capital distributions

 

·

Barclays paid the 2022 full year dividend of 5.0p on 31 March 2023 and completed the £0.5bn share buyback programme announced at FY22 results on 14 April 2023

·

Barclays is committed to maintaining a balance between a strong capital position, delivering total cash returns to shareholders and investment in the business. Barclays pays a progressive ordinary dividend, taking into account these objectives and the earnings outlook of the Group. The Board will also continue to supplement the ordinary dividend as appropriate, including with share buybacks

 

Group capital and leverage

 

·

The CET1 ratio decreased by c.30bps to 13.6% (December 2022: 13.9%) as RWAs increased by £1.9bn to £338.4bn and CET1 capital decreased by £0.9bn to £46.0bn:

-

c.50bps increase from attributable profit generated in the quarter

-

c.40bps aggregate decrease from expected capital impacts in Q123, including the £0.5bn share buyback announced at FY22 results, the impact of regulatory change on 1 January 2023 relating to IFRS 9 transitional relief, and the impact of the KMC acquisition

-

c.20bps decrease as a result of a £5.2bn increase in RWAs primarily driven by increased client and trading activity within Global Markets

-

c.20bps decrease primarily due to increased regulatory capital deductions and an accrual for the FY23 dividend

-

A £4.0bn decrease in RWAs as a result of foreign exchange movements was broadly offset by a £0.5bn decrease in the currency translation reserve

·

The UK leverage ratio decreased to 5.1% (December 2022: 5.3%) primarily due to a £38.9bn increase in leverage exposure and a £0.4bn decrease in Tier 1 capital. The UK leverage exposure increased to £1,168.9bn (December 2022: £1,130.0bn) largely due to an increase in securities financing transactions (SFT) client and trading activity within Global Markets

 

Group funding and liquidity

 

·

The liquidity and funding position remains robust and strengthened further in Q123. The liquidity pool increased to £333.0bn (December 2022: £318.0bn) driven by growth in deposits and increased wholesale funding. The composition of the liquidity pool is conservative, with 82% held in cash and deposits with central banks and the remainder primarily held in high quality government bonds, materially held at fair value or hedged

·

The strength of the funding and liquidity position is supported by a diverse and stable deposit franchise. Total deposits increased to £555.7bn (December 2022: £545.8bn)

·

The liquidity coverage ratio remained significantly above the 100% regulatory requirement at 163% (December 2022: 165%), equivalent to a surplus of £122.0bn (December 2022: £116.4bn)

·

Net Stable Funding Ratio (average of last four quarter ends) was 139% (December 2022: 137%), which represents a £166.7bn (December 2022: £155.6bn) surplus above 100% regulatory requirement

·

Wholesale funding outstanding, excluding repurchase agreements, was £192.2bn (December 2022: £184.0bn)

·

The Group issued £2.8bn equivalent of minimum requirement for own funds and eligible liabilities (MREL) instruments from Barclays PLC (the Parent company) in Q123. The Group has a strong MREL position with a ratio of 32.7%, which is in excess of the regulatory requirement of 29% plus a confidential, institution specific, Prudential Regulation Authority (PRA) buffer

 

Other matters

 

·

KMC acquisition: further to the announcement in Q222, on 1 March 2023 Barclays completed the acquisition of UK specialist mortgage lender KMC, including a portfolio of mortgages totalling £2.2bn with an RWA impact of £0.8bn. The transaction broadens Barclays' existing mortgage product range by adding a leading UK specialist residential mortgage lender with an established track record in the UK market, further enhancing its product capabilities consistent with Barclays' strategic priority to deliver next-generation, digitised consumer financial services

 

Anna Cross, Group Finance Director

 

Results by Business

 

Barclays UK

Three months ended

31.03.23

31.03.22

Income statement information

£m

£m

% Change

Net interest income

1,618

1,339

21

Net fee, commission and other income

343

310

11

Total income

1,961

1,649

19

Operating costs

(1,092)

(998)

(9)

Litigation and conduct

(2)

(9)

78

Total operating expenses

(1,094)

(1,007)

(9)

Other net income

-

-

Profit before impairment

867

642

35

Credit impairment charges

(113)

(48)

Profit before tax

754

594

27

Attributable profit

515

396

30

Performance measures

Return on average allocated tangible equity

20.0%

15.6%

Average allocated tangible equity (£bn)

10.3

10.1

Cost: income ratio

56%

61%

Loan loss rate (bps)

20

9

Net interest margin

3.18%

2.62%

As at 31.03.23

As at 31.12.22

As at 31.03.22

Balance sheet information

£bn

£bn

£bn

Loans and advances to customers at amortised cost

208.2

205.1

207.3

Total assets

308.6

313.2

317.2

Customer deposits at amortised cost

254.3

258.0

260.3

Loan: deposit ratio

90%

87%

85%

Risk weighted assets

74.6

73.1

72.7

Period end allocated tangible equity

10.3

10.1

10.1

 

Analysis of Barclays UK

Three months ended

31.03.23

31.03.22

Analysis of total income

£m

£m

% Change

Personal Banking

1,253

1,022

23

Barclaycard Consumer UK

247

276

(11)

Business Banking

461

351

31

Total income

1,961

1,649

19

Analysis of credit impairment charges

Personal Banking

(28)

21

Barclaycard Consumer UK

(83)

(44)

(89)

Business Banking

(2)

(25)

92

Total credit impairment charges

(113)

(48)

 

As at 31.03.23

As at 31.12.22

As at 31.03.22

Analysis of loans and advances to customers at amortised cost

£bn

£bn

£bn

Personal Banking

173.6

169.7

166.5

Barclaycard Consumer UK

9.0

9.2

8.4

Business Banking

25.6

26.2

32.4

Total loans and advances to customers at amortised cost

208.2

205.1

207.3

Analysis of customer deposits at amortised cost

Personal Banking

194.3

195.6

196.6

Barclaycard Consumer UK

-

-

-

Business Banking

60.0

62.4

63.7

Total customer deposits at amortised cost

254.3

258.0

260.3

 

 

Barclays International

Three months ended

31.03.23

31.03.22

Income statement information

£m

£m

% Change

Net interest income

1,354

936

45

Net trading income

2,419

2,446

(1)

Net fee, commission and other income

1,509

1,442

5

Total income

5,282

4,824

9

Operating costs

(2,956)

(2,505)

(18)

Litigation and conduct

3

(513)

Total operating expenses

(2,953)

(3,018)

2

Other net income

3

8

(63)

Profit before impairment

2,332

1,814

29

Credit impairment charges

(404)

(101)

Profit before tax

1,928

1,713

13

Attributable profit

1,348

1,300

4

Performance measures

Return on average allocated tangible equity

14.5%

14.8%

Average allocated tangible equity (£bn)

37.1

35.1

Cost: income ratio

56%

63%

Loan loss rate (bps)

94

28

Net interest margin

5.87%

4.15%

As at 31.03.23

As at 31.12.22

As at 31.03.22

Balance sheet information

£bn

£bn

£bn

Loans and advances to customers at amortised cost

131.0

133.7

113.9

Loans and advances to banks at amortised cost

9.8

8.7

10.2

Debt securities at amortised cost

30.8

27.2

20.7

Loans and advances at amortised cost

171.6

169.6

144.8

Trading portfolio assets

137.7

133.8

134.1

Derivative financial instrument assets

256.6

301.7

288.8

Financial assets at fair value through the income statement

245.0

210.5

203.8

Cash collateral and settlement balances

125.5

107.7

132.0

Other assets

275.0

258.0

255.5

Total assets

1,211.4

1,181.3

1,159.0

Deposits at amortised cost

301.6

287.6

286.1

Derivative financial instrument liabilities

246.7

288.9

277.2

Loan: deposit ratio

57%

59%

51%

Risk weighted assets

255.1

254.8

245.1

Period end allocated tangible equity

36.8

36.8

35.6

 

Analysis of Barclays International

Corporate and Investment Bank

Three months ended

31.03.23

31.03.22

Income statement information

£m

£m

% Change

Net interest income

465

385

21

Net trading income

2,437

2,450

(1)

Net fee, commission and other income

1,074

1,103

(3)

Total income

3,976

3,938

1

Operating costs

(2,202)

(1,921)

(15)

Litigation and conduct

3

(318)

Total operating expenses

(2,199)

(2,239)

2

Other net income

-

-

Profit before impairment

1,777

1,699

5

Credit impairment (charges)/releases

(33)

33

Profit before tax

1,744

1,732

1

Attributable profit

1,209

1,316

(8)

Performance measures

Return on average allocated tangible equity

15.2%

17.1%

Average allocated tangible equity (£bn)

31.8

30.8

Cost: income ratio

55%

57%

Loan loss rate (bps)

10

(12)

As at 31.03.23

As at 31.12.22

As at 31.03.22

Balance sheet information

£bn

£bn

£bn

Loans and advances to customers at amortised cost

89.2

90.5

79.5

Loans and advances to banks at amortised cost

9.2

8.1

9.4

Debt securities at amortised cost

30.7

27.2

20.7

Loans and advances at amortised cost

129.1

125.8

109.6

Trading portfolio assets

137.6

133.7

134.0

Derivative financial instrument assets

256.5

301.6

288.7

Financial assets at fair value through the income statement

244.9

210.5

203.8

Cash collateral and settlement balances

124.7

106.9

131.2

Other assets

230.3

222.6

222.5

Total assets

1,123.1

1,101.1

1,089.8

Deposits at amortised cost

221.0

205.8

214.7

Derivative financial instrument liabilities

246.7

288.9

277.1

Risk weighted assets

216.8

215.9

213.5

Three months ended

31.03.23

31.03.22

Analysis of total income

£m

£m

% Change

FICC

1,788

1,644

9

Equities

704

1,052

(33)

Global Markets

2,492

2,696

(8)

Advisory

212

185

15

Equity capital markets

50

47

6

Debt capital markets

341

416

(18)

Investment Banking fees

603

648

(7)

Corporate lending

95

125

(24)

Transaction banking

786

469

68

Corporate

881

594

48

Total income

3,976

3,938

1

 

Analysis of Barclays International

Consumer, Cards and Payments

Three months ended

31.03.23

31.03.22

Income statement information

£m

£m

% Change

Net interest income

889

551

61

Net fee, commission, trading and other income

417

335

24

Total income

1,306

886

47

Operating costs

(754)

(584)

(29)

Litigation and conduct

-

(195)

Total operating expenses

(754)

(779)

3

Other net income

3

8

(63)

Profit before impairment

555

115

 

Credit impairment charges

(371)

(134)

Profit/(loss) before tax

184

(19)

 

Attributable profit/(loss)

139

(16)

Performance measures

Return on average allocated tangible equity

10.5%

(1.5)%

Average allocated tangible equity (£bn)

5.3

4.3

Cost: income ratio

58%

88%

Loan loss rate (bps)

332

145

As at 31.03.23

As at 31.12.22

As at 31.03.22

Balance sheet information

£bn

£bn

£bn

Loans and advances to customers at amortised cost

41.8

43.2

34.4

Total assets

88.3

80.2

69.2

Deposits at amortised cost

80.6

81.8

71.4

Risk weighted assets

38.2

38.9

31.6

Three months ended

31.03.23

31.03.22

Analysis of total income

£m

£m

% Change

International Cards and Consumer Bank

900

538

67

Private Bank

258

214

21

Payments

148

134

10

Total income

1,306

886

47

 

Head Office

Three months ended

31.03.23

31.03.22

Income statement information

£m

£m

% Change

Net interest income

81

66

23

Net fee, commission and other income

(87)

(43)

Total income

(6)

23

 

Operating costs

(63)

(85)

26

Litigation and conduct

-

(1)

Total operating expenses

(63)

(86)

27

Other net expenses

(8)

(18)

56

Loss before impairment

(77)

(81)

5

Credit impairment (charges)/releases

(7)

8

Loss before tax

(84)

(73)

(15)

Attributable loss

(80)

(292)

73

Performance measures

Average allocated tangible equity (£bn)

0.2

3.6

As at 31.03.23

As at 31.12.22

As at 31.03.22

Balance sheet information

£bn

£bn

£bn

Total assets

19.1

19.2

19.9

Risk weighted assets

8.8

8.6

11.0

Period end allocated tangible equity

0.2

(0.2)

3.6

 

Quarterly Results Summary

 

Barclays Group

Q123

Q422

Q322

Q222

Q122

Q4211

Q3211

Q2211

Income statement information

£m

£m

£m

£m

£m

£m

£m

£m

Net interest income

3,053

2,741

3,068

2,422

2,341

2,230

1,940

2,052

Net fee, commission and other income

4,184

3,060

2,883

4,286

4,155

2,930

3,525

3,363

Total income

7,237

5,801

5,951

6,708

6,496

5,160

5,465

5,415

Operating costs

(4,111)

(3,748)

(3,939)

(3,682)

(3,588)

(3,514)

(3,446)

(3,587)

UK bank levy

-

(176)

-

-

-

(170)

-

-

Litigation and conduct

1

(79)

339

(1,334)

(523)

(92)

(129)

(143)

Total operating expenses

(4,110)

(4,003)

(3,600)

(5,016)

(4,111)

(3,776)

(3,575)

(3,730)

Other net (expenses)/income

(5)

10

(1)

7

(10)

13

94

21

Profit before impairment

3,122

1,808

2,350

1,699

2,375

1,397

1,984

1,706

Credit impairment (charges)/releases

(524)

(498)

(381)

(200)

(141)

31

(120)

797

Profit before tax

2,598

1,310

1,969

1,499

2,234

1,428

1,864

2,503

Tax (charge)/credit

(561)

33

(249)

(209)

(614)

(104)

(292)

(246)

Profit after tax

2,037

1,343

1,720

1,290

1,620

1,324

1,572

2,257

Non-controlling interests

(8)

(22)

(2)

(20)

(1)

(27)

(1)

(15)

Other equity instrument holders

(246)

(285)

(206)

(199)

(215)

(218)

(197)

(194)

Attributable profit

1,783

1,036

1,512

1,071

1,404

1,079

1,374

2,048

Performance measures

Return on average tangible shareholders' equity

15.0%

8.9%

12.5%

8.7%

11.5%

9.0%

11.4%

17.6%

Average tangible shareholders' equity (£bn)

47.6

46.7

48.6

49.0

48.8

48.0

48.3

46.5

Cost: income ratio

57%

69%

60%

75%

63%

73%

65%

69%

Loan loss rate (bps)

52

49

36

20

15

(3)

13

(90)

Basic earnings per share

11.3p

6.5p

9.4p

6.4p

8.4p

6.4p

8.0p

11.9p

Basic weighted average number of shares (m)

15,770

15,828

16,148

16,684

16,682

16,985

17,062

17,140

Period end number of shares (m)

15,701

15,871

15,888

16,531

16,762

16,752

16,851

16,998

Balance sheet and capital management2

£bn

£bn

£bn

£bn

£bn

£bn

£bn

£bn

Loans and advances to customers at amortised cost

343.6

343.3

346.3

337.2

325.8

319.9

313.5

309.2

Loans and advances to banks at amortised cost

11.0

10.0

12.5

12.5

11.4

9.7

10.6

11.0

Debt securities at amortised cost

48.9

45.5

54.8

46.1

34.5

31.8

28.9

28.3

Loans and advances at amortised cost

403.5

398.8

413.7

395.8

371.7

361.5

353.0

348.5

Loans and advances at amortised cost impairment coverage ratio

1.4%

1.4%

1.4%

1.4%

1.5%

1.6%

1.7%

1.8%

Total assets

1,539.1

1,513.7

1,726.9

1,589.2

1,496.1

1,384.3

1,406.5

1,376.3

Deposits at amortised cost

555.7

545.8

574.4

568.7

546.5

519.4

510.2

500.9

Tangible net asset value per share

301p

295p

286p

297p

294p

291p

286p

280p

Common equity tier 1 ratio

13.6%

13.9%

13.8%

13.6%

13.8%

15.1%

15.3%

15.0%

Common equity tier 1 capital

46.0

46.9

48.6

46.7

45.3

47.3

47.2

46.2

Risk weighted assets

338.4

336.5

350.8

344.5

328.8

314.1

307.7

307.4

UK leverage ratio

5.1%

5.3%

5.0%

5.1%

5.0%

5.2%

5.1%

5.0%

UK leverage exposure

1,168.9

1,130.0

1,232.1

1,151.2

1,123.5

1,137.9

1,162.7

1,154.9

Average UK leverage ratio

4.8%

4.8%

4.8%

4.7%

4.8%

4.9%

4.9%

4.8%

Average UK leverage exposure

1,251.3

1,281.0

1,259.6

1,233.5

1,179.4

1,229.0

1,201.1

1,192.7

Funding and liquidity

Group liquidity pool (£bn)

333.0

318.0

325.8

342.5

319.8

291.0

292.8

290.8

Liquidity coverage ratio

163%

165%

151%

156%

159%

168%

161%

162%

Net stable funding ratio3

139%

137%

Loan: deposit ratio

73%

73%

72%

70%

68%

70%

69%

70%

 

1

The comparative capital and financial metrics relating to Q221 - Q421 have been restated to reflect the impact of the Over-issuance of Securities.

2

Refer to pages 29 to 34 for further information on how capital, RWAs and leverage are calculated.

3

Represents average of the last four spot quarter end positions.

 

Quarterly Results by Business

 

Barclays UK

Q123

Q422

Q322

Q222

Q122

Q421

Q321

Q221

Income statement information

£m

£m

£m

£m

£m

£m

£m

£m

Net interest income

1,618

1,600

1,561

1,393

1,339

1,313

1,303

1,305

Net fee, commission and other income

343

370

355

331

310

386

335

318

Total income

1,961

1,970

1,916

1,724

1,649

1,699

1,638

1,623

Operating costs

(1,092)

(1,108)

(1,069)

(1,085)

(998)

(1,202)

(1,041)

(1,078)

UK bank levy

-

(26)

-

-

-

(36)

-

-

Litigation and conduct

(2)

(13)

(3)

(16)

(9)

(5)

(10)

(19)

Total operating expenses

(1,094)

(1,147)

(1,072)

(1,101)

(1,007)

(1,243)

(1,051)

(1,097)

Other net income/(expenses)

-

1

(1)

-

-

(1)

1

-

Profit before impairment

867

824

843

623

642

455

588

526

Credit impairment (charges)/releases

(113)

(157)

(81)

-

(48)

59

(137)

520

Profit before tax 

754

667

762

623

594

514

451

1,046

Attributable profit

515

474

549

458

396

420

317

721

Balance sheet information

£bn

£bn

£bn

£bn

£bn

£bn

£bn

£bn

Loans and advances to customers at amortised cost

208.2

205.1

205.1

205.9

207.3

208.8

208.6

207.8

Total assets

308.6

313.2

316.8

318.8

317.2

321.2

312.1

311.2

Customer deposits at amortised cost

254.3

258.0

261.0

261.5

260.3

260.6

256.8

255.5

Loan: deposit ratio

90%

87%

86%

85%

85%

85%

86%

87%

Risk weighted assets

74.6

73.1

73.2

72.2

72.7

72.3

73.2

72.2

Period end allocated tangible equity

10.3

10.1

10.1

9.9

10.1

10.0

10.0

9.9

Performance measures

Return on average allocated tangible equity

20.0%

18.7%

22.1%

18.4%

15.6%

16.8%

12.7%

29.1%

Average allocated tangible equity (£bn)

10.3

10.2

9.9

10.0

10.1

10.0

10.0

9.9

Cost: income ratio

56%

58%

56%

64%

61%

73%

64%

68%

Loan loss rate (bps)

20

27

14

-

9

(10)

24

(93)

Net interest margin

3.18%

3.10%

3.01%

2.71%

2.62%

2.49%

2.49%

2.55%

 

Analysis of Barclays UK

Q123

Q422

Q322

Q222

Q122

Q421

Q321

Q221

Analysis of total income

£m

£m

£m

£m

£m

£m

£m

£m

Personal Banking

1,253

1,229

1,212

1,077

1,022

983

990

987

Barclaycard Consumer UK

247

269

283

265

276

352

293

290

Business Banking

461

472

421

382

351

364

355

346

Total income

1,961

1,970

1,916

1,724

1,649

1,699

1,638

1,623

Analysis of credit impairment (charges)/releases

Personal Banking

(28)

(120)

(26)

(42)

21

8

(30)

72

Barclaycard Consumer UK

(83)

(12)

2

84

(44)

114

(108)

434

Business Banking

(2)

(25)

(57)

(42)

(25)

(63)

1

14

Total credit impairment (charges)/releases

(113)

(157)

(81)

-

(48)

59

(137)

520

Analysis of loans and advances to customers at amortised cost

£bn

£bn

£bn

£bn

£bn

£bn

£bn

£bn

Personal Banking

173.6

169.7

168.7

167.1

166.5

165.4

164.6

162.4

Barclaycard Consumer UK

9.0

9.2

9.0

8.8

8.4

8.7

8.6

8.8

Business Banking

25.6

26.2

27.4

30.0

32.4

34.7

35.4

36.6

Total loans and advances to customers at amortised cost

208.2

205.1

205.1

205.9

207.3

208.8

208.6

207.8

Analysis of customer deposits at amortised cost

Personal Banking

194.3

195.6

197.3

197.0

196.6

196.4

193.3

191.0

Barclaycard Consumer UK

-

-

-

-

-

-

-

0.1

Business Banking

60.0

62.4

63.7

64.5

63.7

64.2

63.5

64.4

Total customer deposits at amortised cost

254.3

258.0

261.0

261.5

260.3

260.6

256.8

255.5

 

Barclays International

Q123

Q422

Q322

Q222

Q122

Q4211

Q3211

Q2211

Income statement information

£m

£m

£m

£m

£m

£m

£m

£m

Net interest income

1,354

1,465

1,497

1,029

936

955

749

811

Net trading income

2,419

1,169

1,328

2,766

2,446

789

1,515

1,455

Net fee, commission and other income

1,509

1,228

1,240

1,321

1,442

1,766

1,673

1,553

Total income

5,282

3,862

4,065

5,116

4,824

3,510

3,937

3,819

Operating costs

(2,956)

(2,543)

(2,776)

(2,537)

(2,505)

(2,160)

(2,310)

(2,168)

UK bank levy

-

(133)

-

-

-

(134)

-

-

Litigation and conduct

3

(67)

396

(1,319)

(513)

(84)

(100)

(140)

Total operating expenses

(2,953)

(2,743)

(2,380)

(3,856)

(3,018)

(2,378)

(2,410)

(2,308)

Other net income

3

5

10

5

8

3

15

13

Profit before impairment

2,332

1,124

1,695

1,265

1,814

1,135

1,542

1,524

Credit impairment (charges)/releases

(404)

(328)

(295)

(209)

(101)

(23)

18

271

Profit before tax

1,928

796

1,400

1,056

1,713

1,112

1,560

1,795

Attributable profit

1,348

625

1,136

783

1,300

818

1,191

1,207

Balance sheet information

£bn

£bn

£bn

£bn

£bn

£bn

£bn

£bn

Loans and advances to customers at amortised cost

131.0

133.7

137.0

126.7

113.9

106.4

99.9

96.3

Loans and advances to banks at amortised cost

9.8

8.7

11.0

11.3

10.2

8.4

9.4

9.9

Debt securities at amortised cost

30.8

27.2

36.2

29.3

20.7

19.0

16.6

15.7

Loans and advances at amortised cost

171.6

169.6

184.2

167.3

144.8

133.8

125.9

121.9

Trading portfolio assets

137.7

133.8

126.3

126.9

134.1

146.9

144.8

147.1

Derivative financial instrument assets

256.6

301.7

415.7

343.5

288.8

261.5

257.0

255.4

Financial assets at fair value through the income statement

245.0

210.5

244.7

209.3

203.8

188.2

200.5

190.4

Cash collateral and settlement balances

125.5

107.7

163.3

128.5

132.0

88.1

115.9

108.5

Other assets

275.0

258.0

257.2

275.1

255.5

225.6

231.8

223.5

Total assets

1,211.4

1,181.3

1,391.4

1,250.6

1,159.0

1,044.1

1,075.9

1,046.8

Deposits at amortised cost

301.6

287.6

313.2

307.4

286.1

258.8

253.3

245.4

Derivative financial instrument liabilities

246.7

288.9

394.2

321.2

277.2

256.4

252.3

246.9

Loan: deposit ratio

57%

59%

59%

54%

51%

52%

50%

50%

Risk weighted assets

255.1

254.8

269.3

263.8

245.1

230.9

222.7

223.2

Period end allocated tangible equity

36.8

36.8

38.8

38.0

35.6

33.2

31.8

31.8

Performance measures

Return on average allocated tangible equity

14.5%

6.4%

11.6%

8.4%

14.8%

9.9%

14.9%

14.9%

Average allocated tangible equity (£bn)

37.1

38.9

39.1

37.3

35.1

32.9

31.8

32.4

Cost: income ratio

56%

71%

59%

75%

63%

68%

61%

60%

Loan loss rate (bps)

94

75

62

49

28

7

(6)

(87)

Net interest margin

5.87%

5.71%

5.58%

4.52%

4.15%

4.14%

4.02%

3.96%

 

1

The comparative capital and financial metrics relating to Q221 - Q421 have been restated to reflect the impact of the Over-issuance of Securities.

 

Analysis of Barclays International

Corporate and Investment Bank

Q123

Q422

Q322

Q222

Q122

Q4211

Q3211

Q2211

Income statement information

£m

£m

£m

£m

£m

£m

£m

£m

Net interest income

465

548

606

410

385

432

279

370

Net trading income

2,437

1,201

1,344

2,738

2,450

774

1,467

1,494

Net fee, commission and other income

1,074

827

871

885

1,103

1,426

1,383

1,115

Total income

3,976

2,576

2,821

4,033

3,938

2,632

3,129

2,979

Operating costs

(2,202)

(1,796)

(2,043)

(1,870)

(1,921)

(1,562)

(1,747)

(1,623)

UK bank levy

-

(126)

-

-

-

(128)

-

-

Litigation and conduct

3

(55)

498

(1,314)

(318)

(59)

(99)

(78)

Total operating expenses

(2,199)

(1,977)

(1,545)

(3,184)

(2,239)

(1,749)

(1,846)

(1,701)

Other net income

-

2

-

-

-

1

-

-

Profit before impairment

1,777

601

1,276

849

1,699

884

1,283

1,278

Credit impairment (charges)/releases

(33)

(41)

(46)

(65)

33

73

128

229

Profit before tax

1,744

560

1,230

784

1,732

957

1,411

1,507

Attributable profit

1,209

454

1,015

579

1,316

695

1,085

989

Balance sheet information

£bn

£bn

£bn

£bn

£bn

£bn

£bn

£bn

Loans and advances to customers at amortised cost

89.2

90.5

93.6

86.5

79.5

73.4

68.3

66.3

Loans and advances to banks at amortised cost

9.2

8.1

10.2

10.0

9.4

7.6

8.9

9.0

Debt securities at amortised cost

30.7

27.2

36.2

29.3

20.7

19.0

16.6

15.7

Loans and advances at amortised cost

129.1

125.8

140.0

125.8

109.6

100.0

93.8

91.0

Trading portfolio assets

137.6

133.7

126.1

126.7

134.0

146.7

144.7

147.0

Derivative financial instruments assets

256.5

301.6

415.5

343.4

288.7

261.5

256.9

255.3

Financial assets at fair value through the income statement

244.9

210.5

244.6

209.2

203.8

188.1

200.4

190.3

Cash collateral and settlement balances

124.7

106.9

162.6

127.7

131.2

87.2

115.1

107.7

Other assets

230.3

222.6

220.6

237.2

222.5

195.8

200.4

192.5

Total assets

1,123.1

1,101.1

1,309.4

1,170.0

1,089.8

979.3

1,011.3

983.8

Deposits at amortised cost

221.0

205.8

229.5

229.5

214.7

189.4

185.8

178.2

Derivative financial instrument liabilities

246.7

288.9

394.2

321.2

277.1

256.4

252.2

246.8

Risk weighted assets

216.8

215.9

230.6

227.6

213.5

200.7

192.5

194.3

Performance measures

Return on average allocated tangible equity

15.2%

5.4%

11.9%

7.1%

17.1%

9.7%

15.6%

14.0%

Average allocated tangible equity (£bn)

31.8

33.7

34.0

32.7

30.8

28.7

27.8

28.4

Cost: income ratio

55%

77%

55%

79%

57%

66%

59%

57%

Loan loss rate (bps)

10

13

13

20

(12)

(29)

(54)

(100)

Analysis of total income

£m

£m

£m

£m

£m

£m

£m

£m

FICC

1,788

976

1,546

1,529

1,644

546

803

895

Equities

704

440

246

1,411

1,052

501

757

777

Global Markets

2,492

1,416

1,792

2,940

2,696

1,047

1,560

1,672

Advisory

212

197

150

236

185

287

253

218

Equity capital markets

50

40

42

37

47

158

186

226

Debt capital markets

341

243

341

281

416

511

532

429

Investment Banking fees

603

480

533

554

648

956

971

873

Corporate lending

95

(128)

(181)

(47)

125

176

168

38

Transaction banking

786

808

677

586

469

453

430

396

Corporate

881

680

496

539

594

629

598

434

Total income

3,976

2,576

2,821

4,033

3,938

2,632

3,129

2,979

 

1

The comparative capital and financial metrics relating to Q221 - Q421 have been restated to reflect the impact of the Over-issuance of Securities.

 

Analysis of Barclays International

Consumer, Cards and Payments

Q123

Q422

Q322

Q222

Q122

Q421

Q321

Q221

Income statement information

£m

£m

£m

£m

£m

£m

£m

£m

Net interest income

889

918

891

619

551

522

471

441

Net fee, commission, trading and other income

417

368

353

464

335

356

337

399

Total income

1,306

1,286

1,244

1,083

886

878

808

840

Operating costs

(754)

(747)

(733)

(667)

(584)

(598)

(563)

(545)

UK bank levy

-

(7)

-

-

-

(6)

-

-

Litigation and conduct

-

(12)

(102)

(5)

(195)

(25)

(1)

(62)

Total operating expenses

(754)

(766)

(835)

(672)

(779)

(629)

(564)

(607)

Other net income

3

3

10

5

8

2

15

13

Profit before impairment

555

523

419

416

115

251

259

246

Credit impairment (charges)/releases

(371)

(287)

(249)

(144)

(134)

(96)

(110)

42

Profit/(loss) before tax

184

236

170

272

(19)

155

149

288

Attributable profit/(loss)

139

171

121

204

(16)

123

106

218

Balance sheet information

£bn

£bn

£bn

£bn

£bn

£bn

£bn

£bn

Loans and advances to customers at amortised cost

41.8

43.2

43.4

40.2

34.4

33.0

31.6

30.0

Total assets

88.3

80.2

82.0

80.6

69.2

64.8

64.6

63.0

Deposits at amortised cost

80.6

81.8

83.7

77.9

71.4

69.4

67.5

67.2

Risk weighted assets

38.2

38.9

38.7

36.2

31.6

30.2

30.2

29.0

Performance measures

Return on average allocated tangible equity

10.5%

13.0%

9.5%

17.8%

(1.5)%

11.7%

10.5%

21.8%

Average allocated tangible equity (£bn)

5.3

5.2

5.1

4.6

4.3

4.2

4.0

4.0

Cost: income ratio

58%

60%

67%

62%

88%

72%

70%

72%

Loan loss rate (bps)

332

245

211

132

145

105

127

(49)

Analysis of total income

£m

£m

£m

£m

£m

£m

£m

£m

International Cards and Consumer Bank

900

860

824

691

538

552

490

517

Private Bank

258

285

270

245

214

200

188

214

Payments

148

141

150

147

134

126

130

109

Total income

1,306

1,286

1,244

1,083

886

878

808

840

 

Head Office

Q123

Q422

Q322

Q222

Q122

Q421

Q321

Q221

Income statement information

£m

£m

£m

£m

£m

£m

£m

£m

Net interest income

81

(324)

10

-

66

(38)

(112)

(64)

Net fee, commission and other income

(87)

293

(40)

(132)

(43)

(11)

2

37

Total income

(6)

(31)

(30)

(132)

23

(49)

(110)

(27)

Operating costs

(63)

(97)

(94)

(60)

(85)

(152)

(95)

(341)

UK bank levy

-

(17)

-

-

-

-

-

-

Litigation and conduct

-

1

(54)

1

(1)

(3)

(19)

16

Total operating expenses

(63)

(113)

(148)

(59)

(86)

(155)

(114)

(325)

Other net (expenses)/income

(8)

4

(10)

2

(18)

11

78

8

Loss before impairment

(77)

(140)

(188)

(189)

(81)

(193)

(146)

(344)

Credit impairment (charges)/releases

(7)

(13)

(5)

9

8

(5)

(1)

6

Loss before tax

(84)

(153)

(193)

(180)

(73)

(198)

(147)

(338)

Attributable (loss)/profit

(80)

(63)

(173)

(170)

(292)

(159)

(134)

120

Balance sheet information

£bn

£bn

£bn

£bn

£bn

£bn

£bn

£bn

Total assets

19.1

19.2

18.7

19.8

19.9

19.0

18.5

18.3

Risk weighted assets1

8.8

8.6

8.2

8.6

11.0

11.0

11.8

12.0

Period end allocated tangible equity1

0.2

(0.2)

(3.5)

1.1

3.6

5.5

6.3

5.9

Performance measures1

Average allocated tangible equity (£bn)

0.2

(2.4)

(0.4)

1.7

3.6

5.1

6.5

4.2

 

1

The comparative capital and financial metrics relating to Q221 - Q421 have been restated to reflect the impact of the Over-issuance of Securities.

 

 

Performance Management

 

Margins and balances

Three months ended 31.03.23

Three months ended 31.03.22

Net interest income

Average customer assets

Net interest margin

Net interest income

Average customer assets

Net interest margin

£m

£m

%

£m

£m

%

Barclays UK

1,618

206,241

3.18

1,339

207,607

2.62

Corporate and Investment Bank1

551

56,612

3.95

316

50,798

2.52

Consumer, Cards and Payments

889

42,840

8.42

551

34,040

6.56

Barclays International1

1,440

99,452

5.87

867

84,838

4.15

Total Barclays UK and Barclays International

3,058

305,693

4.06

2,206

292,445

3.06

Other2

(5)

135

Total Barclays Group

3,053

2,341

 

1

CIB and Barclays International margins include the lending related investment bank business.

2

Other includes Head Office and the non-lending related investment bank businesses not included in Barclays International margins.

 

The Barclays UK and Barclays International NIM has increased 100bps from 3.06% in Q122 to 4.06% in Q123, driven by the higher interest rate environment and continued structural hedge income momentum across the Group, higher balances in CC&P including the Gap portfolio acquisition, partially offset by Mortgage margin compression and lower interest-earning lending in UK Cards.

 

The Group's combined product and equity structural hedge notional amount as at 31 March 2023 was £260bn (31 March 2022: £238bn), with an average duration of close to 2.5 years (2022: average duration close to 3 years). Gross structural hedge contributions of £773m (Q122: £378m) and net structural hedge contributions of £(1,709)m (Q122: £141m) are included in Group net interest income. Gross structural hedge contributions represent the absolute level of interest earned from the fixed receipts on swaps in the structural hedge, while the net structural hedge contributions represent the net interest earned on the difference between the structural hedge rate and prevailing floating rates.

 

Quarterly analysis for Barclays UK and Barclays International

Net interest income

 

Average customer assets

Net interest margin

Three months ended 31.12.22

£m

£m

%

Barclays UK

1,600

204,941

3.10

Corporate and Investment Bank

556

59,146

3.73

Consumer, Cards and Payments

918

43,319

8.40

Barclays International1

1,474

102,465

5.71

Total Barclays UK and Barclays International

3,074

307,406

3.97

Three months ended 30.09.22

Barclays UK

1,561

205,881

3.01

Corporate and Investment Bank

529

58,891

3.56

Consumer, Cards and Payments

891

42,019

8.41

Barclays International1

1,420

100,910

5.58

Total Barclays UK and Barclays International

2,981

306,791

3.85

Three months ended 30.06.22

Barclays UK

1,393

205,834

2.71

Corporate and Investment Bank

397

55,181

2.88

Consumer, Cards and Payments

619

37,190

6.68

Barclays International1

1,016

92,371

4.41

Total Barclays UK and Barclays International

2,409

298,205

3.24

Three months ended 31.03.22

Barclays UK

1,339

207,607

2.62

Corporate and Investment Bank

316

50,798

2.52

Consumer, Cards and Payments

551

34,040

6.56

Barclays International1

867

84,838

4.15

Total Barclays UK and Barclays International

2,206

292,445

3.06

 

1

CIB and Barclays International margins include the lending related investment bank business.

 

Credit Risk

 

Loans and advances at amortised cost by stage

 

The table below presents a stage allocation and business segment analysis of loans and advances at amortised cost by gross exposure, impairment allowance, impairment charge and coverage ratio as at 31 March 2023. Also included are stage allocation of off-balance sheet loan commitments and financial guarantee contracts by gross exposure, impairment allowance and coverage as at 31 March 2023.

 

Impairment allowance under IFRS 9 considers both the drawn and the undrawn counterparty exposure. For retail portfolios, the total impairment allowance is allocated to gross loans and advances to the extent allowance does not exceed the drawn exposure and any excess is reported on the liabilities side of the balance sheet as a provision. For wholesale portfolios, impairment allowance on undrawn exposure is reported on the liability side of the balance sheet as a provision.

 

Gross exposure

Impairment allowance

Net exposure

Stage 1

Stage 2

Stage 3

Total

Stage 1

Stage 2

Stage 3

Total

As at 31.03.23

£m

£m

£m

£m

£m

£m

£m

£m

£m

Barclays UK

163,313

25,272

2,453

191,038

272

729

489

1,490

189,548

Barclays International

32,359

4,615

1,855

38,829

373

1,243

1,065

2,681

36,148

Head Office

3,435

281

577

4,293

3

26

324

353

3,940

Total Barclays Group retail

199,107

30,168

4,885

234,160

648

1,998

1,878

4,524

229,636

Barclays UK

34,603

3,086

790

38,479

74

110

91

275

38,204

Barclays International

122,198

12,971

1,232

136,401

279

240

401

920

135,481

Head Office

227

-

17

244

-

-

17

17

227

Total Barclays Group wholesale1

157,028

16,057

2,039

175,124

353

350

509

1,212

173,912

Total loans and advances at amortised cost

356,135

46,225

6,924

409,284

1,001

2,348

2,387

5,736

403,548

Off-balance sheet loan commitments and financial guarantee contracts2

368,634

26,320

1,175

396,129

225

307

22

554

395,575

Total3

724,769

72,545

8,099

805,413

1,226

2,655

2,409

6,290

799,123

As at 31.03.23

Three months ended 31.03.23

Coverage ratio

Loan impairment charge/(release) and loan loss rate

Stage 1

Stage 2

Stage 3

Total

Loan impairment charge/(release)

Loan loss rate

%

%

%

%

£m

bps

Barclays UK

0.2

2.9

19.9

0.8

147

31

Barclays International

1.2

26.9

57.4

6.9

368

384

Head Office

0.1

9.3

56.2

8.2

7

66

Total Barclays Group retail

0.3

6.6

38.4

1.9

522

90

Barclays UK

0.2

3.6

11.5

0.7

(41)

Barclays International

0.2

1.9

32.5

0.7

61

18

Head Office

-

-

100.0

7.0

-

Total Barclays Group wholesale1

0.2

2.2

25.0

0.7

20

5

Total loans and advances at amortised cost

0.3

5.1

34.5

1.4

542

54

Off-balance sheet loan commitments and financial guarantee contracts2

0.1

1.2

1.9

0.1

(16)

Other financial assets subject to impairment3

(2)

Total4

0.2

3.7

29.7

0.8

524

 

1

Includes Wealth UK and Private Banking exposures measured on an individual customer exposure basis and excludes Business Banking exposures, including lending under the government backed Bounce Back Loan Scheme (BBLS) of £6bn that are managed on a collective basis and reported within Barclays UK Retail. The net impact is a difference in total exposure of £3.4bn of balances reported as wholesale loans on page 24 in the Loans and advances at amortised cost by product disclosure.

2

Excludes loan commitments and financial guarantees of £12.4bn carried at fair value.

3

Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £197.8bn and impairment allowance of £151m. This comprises £10m ECL on £196.2bn Stage 1 assets, £8m on £1.4bn Stage 2 fair value through other comprehensive income assets, cash collateral and settlement balances and £133m on £146m Stage 3 other assets.

4

The annualised loan loss rate is 52bps after applying the total impairment charge of £524m.

 

Gross exposure

Impairment allowance

Net exposure

Stage 1

Stage 2

Stage 3

Total

Stage 1

Stage 2

Stage 3

Total

As at 31.12.22

£m

£m

£m

£m

£m

£m

£m

£m

£m

Barclays UK

160,424

24,837

2,711

187,972

232

718

485

1,435

186,537

Barclays International

33,735

4,399

1,793

39,927

392

1,200

949

2,541

37,386

Head Office

3,644

252

661

4,557

3

24

359

386

4,171

Total Barclays Group retail

197,803

29,488

5,165

232,456

627

1,942

1,793

4,362

228,094

Barclays UK

34,858

2,954

805

38,617

129

109

96

334

38,283

Barclays International

117,692

14,298

1,098

133,088

301

265

312

878

132,210

Head Office

192

-

18

210

-

-

18

18

192

Total Barclays Group wholesale1

152,742

17,252

1,921

171,915

430

374

426

1,230

170,685

Total loans and advances at amortised cost

350,545

46,740

7,086

404,371

1,057

2,316

2,219

5,592

398,779

Off-balance sheet loan commitments and financial guarantee contracts2

372,945

30,694

1,180

404,819

245

315

23

583

404,236

Total3

723,490

77,434

8,266

809,190

1,302

2,631

2,242

6,175

803,015

As at 31.12.22

Year ended 31.12.22

Coverage ratio

Loan impairment charge/(release) and loan loss rate

Stage 1

Stage 2

Stage 3

Total

Loan impairment charge/(release)

Loan loss rate

%

%

%

%

£m

bps

Barclays UK

0.1

2.9

17.9

0.8

169

9

Barclays International

1.2

27.3

52.9

6.4

763

191

Head Office

0.1

9.5

54.3

8.5

-

Total Barclays Group retail

0.3

6.6

34.7

1.9

932

40

Barclays UK

0.4

3.7

11.9

0.9

106

27

Barclays International

0.3

1.9

28.4

0.7

127

10

Head Office

-

-

100.0

8.6

-

Total Barclays Group wholesale1

0.3

2.2

22.2

0.7

233

14

Total loans and advances at amortised cost

0.3

5.0

31.3

1.4

1,165

29

Off-balance sheet loan commitments and financial guarantee contracts2

0.1

1.0

1.9

0.1

18

Other financial assets subject to impairment3

37

Total4

0.2

3.4

27.1

0.8

1,220

 

1

Includes Wealth UK and Private Banking exposures measured on an individual customer exposure basis and excludes Business Banking exposures, including lending under the government backed Bounce Back Loan Scheme (BBLS) of £6.6bn that are managed on a collective basis and reported within Barclays UK Retail. The net impact is a difference in total exposure of £3.8bn of balances reported as wholesale loans on page 24 in the Loans and advances at amortised cost by product disclosure.

2

Excludes loan commitments and financial guarantees of £14.9bn carried at fair value.

3

Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £180.1bn and impairment allowance of £163m. This comprises £10m ECL on £178.4bn Stage 1 assets, £9m on £1.5bn Stage 2 fair value through other comprehensive income assets, cash collateral and settlement balances and £144m on £149m Stage 3 other assets.

4

The annualised loan loss rate is 30bps after applying the total impairment charge of £1,220m.

 

Loans and advances at amortised cost by product

 

The table below presents a breakdown of loans and advances at amortised cost and the impairment allowance with stage allocation by asset classification.

 

Stage 2

As at 31.03.23

Stage 1

Not past due

>30 days past due

Total

Stage 3

Total

Gross exposure

£m

£m

£m

£m

£m

£m

£m

Home loans

156,635

16,371

1,941

747

19,059

2,323

178,017

Credit cards, unsecured loans and other retail lending

42,655

7,227

377

439

8,043

2,012

52,710

Wholesale loans

156,845

18,840

157

126

19,123

2,589

178,557

Total

356,135

42,438

2,475

1,312

46,225

6,924

409,284

Impairment allowance

Home loans

33

53

13

9

75

412

520

Credit cards, unsecured loans and other retail lending

558

1,541

145

196

1,882

1,349

3,789

Wholesale loans

410

388

3

-

391

626

1,427

Total

1,001

1,982

161

205

2,348

2,387

5,736

Net exposure

Home loans

156,602

16,318

1,928

738

18,984

1,911

177,497

Credit cards, unsecured loans and other retail lending

42,097

5,686

232

243

6,161

663

48,921

Wholesale loans

156,435

18,452

154

126

18,732

1,963

177,130

Total

355,134

40,456

2,314

1,107

43,877

4,537

403,548

Coverage ratio

%

%

%

%

%

%

%

Home loans

-

0.3

0.7

1.2

0.4

17.7

0.3

Credit cards, unsecured loans and other retail lending

1.3

21.3

38.5

44.6

23.4

67.0

7.2

Wholesale loans

0.3

2.1

1.9

-

2.0

24.2

0.8

Total

0.3

4.7

6.5

15.6

5.1

34.5

1.4

As at 31.12.22

Gross exposure

£m

£m

£m

£m

£m

£m

£m

Home loans

153,672

15,990

1,684

526

18,200

2,414

174,286

Credit cards, unsecured loans and other retail lending

44,175

7,126

397

576

8,099

2,122

54,396

Wholesale loans

152,698

20,194

150

97

20,441

2,550

175,689

Total

350,545

43,310

2,231

1,199

46,740

7,086

404,371

Impairment allowance

Home loans

29

53

11

9

73

414

516

Credit cards, unsecured loans and other retail lending

582

1,483

129

220

1,832

1,278

3,692

Wholesale loans

446

403

6

2

411

527

1,384

Total

1,057

1,939

146

231

2,316

2,219

5,592

Net exposure

Home loans

153,643

15,937

1,673

517

18,127

2,000

173,770

Credit cards, unsecured loans and other retail lending

43,593

5,643

268

356

6,267

844

50,704

Wholesale loans

152,252

19,791

144

95

20,030

2,023

174,305

Total

349,488

41,371

2,085

968

44,424

4,867

398,779

Coverage ratio

%

%

%

%

%

%

%

Home loans

-

0.3

0.7

1.7

0.4

17.1

0.3

Credit cards, unsecured loans and other retail lending

1.3

20.8

32.5

38.2

22.6

60.2

6.8

Wholesale loans

0.3

2.0

4.0

2.1

2.0

20.7

0.8

Total

0.3

4.5

6.5

19.3

5.0

31.3

1.4

 

 

Measurement uncertainty

 

The Q123 ECL provision has been based on macroeconomic indicators used in the Q422 ECL scenario, rolled forward by one quarter, and updated to reflect changes in balances, risk parameters and individually assessed impaired names during the quarter. Management has applied economic uncertainty and other adjustments to modelled ECL outputs.

 

Key baseline macroeconomic indicators have been tracked against consensus updates to March 2023. Relative to Q422, these latest updates reflect slight improvements in certain key macroeconomic variables, along with deterioration in UK medium-term unemployment and HPI. When compared against the Q422 scenario, the current consensus remains materially in line. Hence these updates have not been reflected in the Q123 ECL modelled provision level.

 

In addition, coverage levels have been assessed in light of the potential impact of elevated levels of inflation on customer affordability and expert judgements updated accordingly with the resulting adjustments included within total post model adjustments of £0.3bn (31 December 2022: £0.3bn).

 

The following tables show the key macroeconomic variables used in the five scenarios (5 year annual paths) and the probability weights applied to each scenario.

 

Baseline average macroeconomic variables used in the calculation of ECL

2023

2024

2025

2026

2027

As at 31.03.23

%

%

%

%

%

UK GDP1

(0.6)

0.5

1.6

1.9

1.8

UK unemployment2

4.3

4.6

4.2

4.2

4.2

UK HPI3

(4.2)

(2.5)

1.7

2.2

2.2

UK bank rate

4.2

4.3

3.8

3.6

3.3

US GDP1

0.4

0.9

1.5

1.5

1.5

US unemployment4

4.1

4.7

4.7

4.7

4.7

US HPI5

1.5

1.5

2.1

2.4

2.4

US federal funds rate

4.7

3.9

3.2

3.0

3.0

2022

2023

2024

2025

2026

As at 31.12.22

%

%

%

%

%

UK GDP1

3.3

(0.8)

0.9

1.8

1.9

UK unemployment2

3.7

4.5

4.4

4.1

4.2

UK HPI3

8.4

(4.7)

(1.7)

2.2

2.2

UK bank rate

1.8

4.4

4.1

3.8

3.4

US GDP1

1.8

0.5

1.2

1.5

1.5

US unemployment4

3.7

4.3

4.7

4.7

4.7

US HPI5

11.2

1.8

1.5

2.3

2.4

US federal funds rate

2.1

4.8

3.6

3.1

3.0

 

1

Average Real GDP seasonally adjusted change in year.

2

Average UK unemployment rate 16-year+.

3

Change in year end UK HPI = Halifax All Houses, All Buyers index, relative to prior year end.

4

Average US civilian unemployment rate 16-year+.

5

Change in year end US HPI = FHFA House Price Index, relative to prior year end.

 

Downside 2 average economic variables used in the calculation of ECL

2023

2024

2025

2026

2027

As at 31.03.23

%

%

%

%

%

UK GDP1

(2.0)

(4.8)

1.0

2.4

1.9

UK unemployment2

5.0

8.2

8.1

7.5

6.9

UK HPI3

(13.6)

(19.6)

(13.9)

8.2

8.2

UK bank rate

6.1

8.0

6.9

5.8

4.5

US GDP1

(1.3)

(4.5)

1.0

2.8

1.8

US unemployment4

4.9

8.4

8.3

7.3

6.2

US HPI5

(2.1)

(3.9)

(4.1)

4.8

4.8

US federal funds rate

5.9

7.0

6.1

4.9

3.8

2022

2023

2024

2025

2026

As at 31.12.22

%

%

%

%

%

UK GDP1

3.3

(3.4)

(3.8)

2.0

2.3

UK unemployment2

3.7

6.0

8.4

8.0

7.4

UK HPI3

8.4

(18.3)

(18.8)

(7.7)

8.2

UK bank rate

1.8

7.3

7.9

6.6

5.5

US GDP1

1.8

(2.7)

(3.4)

2.0

2.6

US unemployment4

3.7

6.0

8.5

8.1

7.1

US HPI5

11.2

(3.1)

(4.0)

(1.9)

4.8

US federal funds rate

2.1

6.6

6.9

5.8

4.6

 

1

Average Real GDP seasonally adjusted change in year.

2

Average UK unemployment rate 16-year+.

3

Change in year end UK HPI = Halifax All Houses, All Buyers index, relative to prior year end.

4

Average US civilian unemployment rate 16-year+.

5

Change in year end US HPI = FHFA House Price Index, relative to prior year end.

 

Downside 1 average economic variables used in the calculation of ECL

2023

2024

2025

2026

2027

As at 31.03.23

%

%

%

%

%

UK GDP1

(1.3)

(2.2)

1.3

2.2

1.8

UK unemployment2

4.6

6.4

6.1

5.8

5.5

UK HPI3

(9.0)

(11.3)

(6.3)

5.2

5.2

UK bank rate

5.2

6.2

5.4

4.8

3.9

US GDP1

(0.4)

(1.8)

1.2

2.2

1.7

US unemployment4

4.5

6.5

6.5

6.0

5.4

US HPI5

(0.3)

(1.2)

(1.0)

3.6

3.6

US federal funds rate

5.4

5.6

4.6

4.0

3.4

2022

2023

2024

2025

2026

As at 31.12.22

%

%

%

%

%

UK GDP1

3.3

(2.1)

(1.5)

1.9

2.1

UK unemployment2

3.7

5.2

6.4

6.0

5.8

UK HPI3

8.4

(11.7)

(10.6)

(2.8)

5.2

UK bank rate

1.8

5.9

6.1

5.3

4.6

US GDP1

1.8

(1.1)

(1.1)

1.7

2.1

US unemployment4

3.7

5.1

6.6

6.4

5.9

US HPI5

11.2

(0.7)

(1.3)

0.2

3.6

US federal funds rate

2.1

5.8

5.4

4.4

3.9

 

1

Average Real GDP seasonally adjusted change in year.

2

Average UK unemployment rate 16-year+.

3

Change in year end UK HPI = Halifax All Houses, All Buyers index, relative to prior year end.

4

Average US civilian unemployment rate 16-year+.

5

Change in year end US HPI = FHFA House Price Index, relative to prior year end.

 

Upside 2 average economic variables used in the calculation of ECL

2023

2024

2025

2026

2027

As at 31.03.23

%

%

%

%

%

UK GDP1

1.7

4.1

3.1

2.5

2.3

UK unemployment2

3.6

3.4

3.4

3.4

3.4

UK HPI3

5.3

9.6

4.3

4.3

3.5

UK bank rate

3.3

2.8

2.5

2.5

2.5

US GDP1

2.3

3.8

2.9

2.8

2.8

US unemployment4

3.4

3.3

3.3

3.3

3.3

US HPI5

4.6

5.3

4.5

4.5

4.5

US federal funds rate

3.8

3.1

2.8

2.8

2.8

2022

2023

2024

2025

2026

As at 31.12.22

%

%

%

%

%

UK GDP1

3.3

2.8

3.7

2.9

2.4

UK unemployment2

3.7

3.5

3.4

3.4

3.4

UK HPI3

8.4

8.7

7.5

4.4

4.2

UK bank rate

1.8

3.1

2.6

2.5

2.5

US GDP1

1.8

3.3

3.5

2.8

2.8

US unemployment4

3.7

3.3

3.3

3.3

3.3

US HPI5

11.2

5.8

5.1

4.5

4.5

US federal funds rate

2.1

3.6

2.9

2.8

2.8

 

1

Average Real GDP seasonally adjusted change in year.

2

Average UK unemployment rate 16-year+.

3

Change in year end UK HPI = Halifax All Houses, All Buyers index, relative to prior year end.

4

Average US civilian unemployment rate 16-year+.

5

Change in year end US HPI = FHFA House Price Index, relative to prior year end.

 

Upside 1 average economic variables used in the calculation of ECL

2023

2024

2025

2026

2027

As at 31.03.23

%

%

%

%

%

UK GDP1

0.5

2.2

2.3

2.2

2.1

UK unemployment2

3.9

4.0

3.8

3.8

3.8

UK HPI3

0.5

3.4

3.0

3.3

2.8

UK bank rate

3.5

3.3

3.1

2.8

2.8

US GDP1

1.4

2.4

2.2

2.2

2.2

US unemployment4

3.7

4.0

4.0

4.0

4.0

US HPI5

3.0

3.4

3.3

3.4

3.4

US federal funds rate

4.1

3.6

3.0

3.0

3.0

2022

2023

2024

2025

2026

As at 31.12.22

%

%

%

%

%

UK GDP1

3.3

1.0

2.3

2.4

2.1

UK unemployment2

3.7

4.0

3.9

3.8

3.8

UK HPI3

8.4

1.8

2.9

3.3

3.2

UK bank rate

1.8

3.5

3.3

3.0

2.8

US GDP1

1.8

1.9

2.3

2.2

2.2

US unemployment4

3.7

3.8

4.0

4.0

4.0

US HPI5

11.2

3.8

3.3

3.4

3.4

US federal funds rate

2.1

3.9

3.4

3.0

3.0

 

1

Average Real GDP seasonally adjusted change in year.

2

Average UK unemployment rate 16-year+.

3

Change in year end UK HPI = Halifax All Houses, All Buyers index, relative to prior year end.

4

Average US civilian unemployment rate 16-year+.

5

Change in year end US HPI = FHFA House Price Index, relative to prior year end.

 

Scenario probability weighting

Upside 2

Upside 1

Baseline

Downside 1

Downside 2

%

%

%

%

%

As at 31.03.23

Scenario probability weighting

10.9

23.1

39.4

17.6

9.0

As at 31.12.22

Scenario probability weighting

10.9

23.1

39.4

17.6

9.0

 

Treasury and Capital Risk

 

Regulatory minimum requirements

 

Capital

 

The Group's Overall Capital Requirement for CET1 is 11.4% comprising a 4.5% Pillar 1 minimum, a 2.5% Capital Conservation Buffer (CCB), a 1.5% Global Systemically Important Institution (G-SII) buffer, a 2.4% Pillar 2A requirement and a 0.5% Countercyclical Capital Buffer (CCyB).

 

The Group's CCyB is based on the buffer rate applicable for each jurisdiction in which the Group has exposures. On 13 December 2021, the Financial Policy Committee (FPC) announced the re-introduction of a CCyB rate of 1% for UK exposures with effect from 13 December 2022. The buffer rates set by other national authorities for non-UK exposures are not currently material. Overall, this results in a 0.5% CCyB for the Group. On 5 July 2022, the FPC announced that the UK CCyB rate will be increased from 1% to 2% with effect from 5 July 2023.

 

The Group's Pillar 2A requirement as per the PRA's Individual Capital Requirement is 4.3% of which at least 56.25% needs to be met with CET1 capital, equating to 2.4% of RWAs. The Pillar 2A requirement, based on a point in time assessment, has been set as a proportion of RWAs and is subject to at least annual review.

 

The Group's CET1 target ratio of 13-14% takes into account headroom above requirements which includes a confidential institution-specific PRA buffer. The Group remains above its minimum capital regulatory requirements including the PRA buffer.

 

Leverage

 

The Group is subject to a UK leverage ratio requirement of 4.0%. This comprises the 3.25% minimum requirement, a G-SII additional leverage ratio buffer (G-SII ALRB) of 0.53% and a countercyclical leverage ratio buffer (CCLB) of 0.2%. Although the leverage ratio is expressed in terms of Tier 1 (T1) capital, 75% of the minimum requirement, equating to 2.4%, needs to be met with CET1 capital. In addition, the G-SII ALRB and CCLB must be covered solely with CET1 capital. The CET1 capital held against the 0.53% G-SII ALRB was £6.1bn and against the 0.2% CCLB was £2.3bn.

 

The Group is also required to disclose an average UK leverage ratio which is based on capital on the last day of each month in the quarter and an exposure measure for each day in the quarter.

 

MREL

 

The Group is required to meet the higher of: (i) two times the sum of 8% Pillar 1 and 4.3% Pillar 2A equating to 24.5% of RWAs; and (ii) 6.75% of leverage exposures. In addition, the higher of regulatory capital and leverage buffers apply. CET1 capital cannot be counted towards both MREL and the buffers, meaning that the buffers, including the above mentioned confidential institution-specific PRA buffer, will effectively be applied above MREL requirements.

 

In the disclosures that follow, references to CRR, as amended by CRR II, mean the capital regulatory requirements, as they form part of domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended.

 

Capital ratios1,2

As at 31.03.23

As at 31.12.22

CET1

13.6%

13.9%

T1

17.6%

17.9%

Total regulatory capital

20.2%

20.8%

Capital resources

£m

£m

Total equity excluding non-controlling interests per the balance sheet

69,699

68,292

Less: other equity instruments (recognised as AT1 capital)

(13,784)

(13,284)

Adjustment to retained earnings for foreseeable ordinary share dividends

(338)

(787)

Adjustment to retained earnings for foreseeable repurchase of shares

(224)

-

Adjustment to retained earnings for foreseeable other equity coupons

(52)

(37)

Other regulatory adjustments and deductions

Additional value adjustments (PVA)

(1,913)

(1,726)

Goodwill and intangible assets

(8,642)

(8,224)

Deferred tax assets that rely on future profitability excluding temporary differences

(1,435)

(1,500)

Fair value reserves related to gains or losses on cash flow hedges

6,164

7,237

Excess of expected losses over impairment

(232)

(119)

Gains or losses on liabilities at fair value resulting from own credit

(86)

(620)

Defined benefit pension fund assets

(3,593)

(3,430)

Direct and indirect holdings by an institution of own CET1 instruments

(20)

(20)

Adjustment under IFRS 9 transitional arrangements

245

700

Other regulatory adjustments

196

396

CET1 capital

45,985

46,878

AT1 capital

Capital instruments and related share premium accounts

13,784

13,284

Other regulatory adjustments and deductions

(60)

(60)

AT1 capital

13,724

13,224

T1 capital

59,709

60,102

T2 capital

Capital instruments and related share premium accounts

7,538

9,000

Qualifying T2 capital (including minority interests) issued by subsidiaries

1,061

1,095

Credit risk adjustments (excess of impairment over expected losses)

66

35

Other regulatory adjustments and deductions

(160)

(160)

Total regulatory capital

68,214

70,072

Total RWAs

338,448

336,518

 

1

CET1, T1 and T2 capital, and RWAs are calculated applying the transitional arrangements of the CRR as amended by CRR II. This includes IFRS 9 transitional arrangements and the grandfathering of CRR II non-compliant capital instruments.

2

The fully loaded CET1 ratio, as is relevant for assessing against the conversion trigger in Barclays PLC AT1 securities, was 13.5%, with £45.7bn of CET1 capital and £338.4bn of RWAs calculated without applying the transitional arrangements of the CRR as amended by CRR II.

 

Movement in CET1 capital

Three months ended 31.03.23

£m

Opening CET1 capital

46,878

Profit for the period attributable to equity holders

2,029

Own credit relating to derivative liabilities

(6)

Ordinary share dividends paid and foreseen

(344)

Purchased and foreseeable share repurchase

(500)

Other equity coupons paid and foreseen

(261)

Increase in retained regulatory capital generated from earnings

918

Net impact of share schemes

(290)

Fair value through other comprehensive income reserve

149

Currency translation reserve

(531)

Other reserves

2

Decrease in other qualifying reserves

(670)

Pension remeasurements within reserves

135

Defined benefit pension fund asset deduction

(163)

Net impact of pensions

(28)

Additional value adjustments (PVA)

(187)

Goodwill and intangible assets

(418)

Deferred tax assets that rely on future profitability excluding those arising from temporary differences

65

Excess of expected loss over impairment

(113)

Adjustment under IFRS 9 transitional arrangements

(455)

Other regulatory adjustments

(5)

Decrease in regulatory capital due to adjustments and deductions

(1,113)

Closing CET1 capital

45,985

 

CET1 capital decreased £0.9bn to £46.0bn (December 2022: £46.9bn).

£2.0bn of capital generated from profit was partially offset by distributions of £1.1bn comprising:

·

£0.5bn of buybacks announced with FY22 results

·

£0.3bn accrual towards a FY23 dividend

·

£0.3bn of equity coupons paid and foreseen

Other significant movements in the period were:

·

£0.5bn decrease in the currency translation reserve driven by the depreciation of period end USD against GBP

·

£0.4bn increase in the goodwill and intangibles deduction primarily as a result of the acquisition of KMC

·

£0.5bn decrease in IFRS 9 transitional relief primarily due to the relief applied to the pre-2020 impairment charge reducing to 0% in 2023 from 25% in 2022 and the relief applied to the post-2022 impairment charge reducing to 50% in 2023 from 75% in 2022.

 

RWAs by risk type and business

Credit risk

Counterparty credit risk

Market Risk

Operational risk

Total RWAs

STD

IRB

STD

IRB

Settlement Risk

CVA

STD

IMA

As at 31.03.23

£m

£m

£m

£m

£m

£m

£m

£m

£m

£m

Barclays UK

7,816

55,174

246

-

-

115

196

-

11,054

74,601

Corporate and Investment Bank

33,904

75,225

17,014

21,692

237

2,811

15,734

23,136

27,093

216,846

Consumer, Cards and Payments

26,511

4,343

205

45

-

60

-

525

6,527

38,216

Barclays International

60,415

79,568

17,219

21,737

237

2,871

15,734

23,661

33,620

255,062

Head Office

2,578

7,016

-

-

-

-

-

-

(809)

8,785

Barclays Group

70,809

141,758

17,465

21,737

237

2,986

15,930

23,661

43,865

338,448

As at 31.12.22

Barclays UK

6,836

54,752

167

-

-

72

233

-

11,023

73,083

Corporate and Investment Bank

35,738

75,413

16,814

21,449

80

3,093

13,716

22,497

27,064

215,864

Consumer, Cards and Payments

27,882

3,773

214

46

-

61

-

388

6,559

38,923

Barclays International

63,620

79,186

17,028

21,495

80

3,154

13,716

22,885

33,623

254,787

Head Office

2,636

6,843

-

-

-

-

-

-

(831)

8,648

Barclays Group

73,092

140,781

17,195

21,495

80

3,226

13,949

22,885

43,815

336,518

 

Movement analysis of RWAs

Credit risk

Counterparty credit risk

Market risk

Operational risk

Total RWAs

£m

£m

£m

£m

£m

Opening RWAs (as at 31.12.22)

213,873

41,996

36,834

43,815

336,518

Book size

(1,091)

1,189

3,051

50

3,199

Acquisitions and disposals

688

-

-

-

688

Book quality

1,039

134

-

-

1,173

Model updates

-

-

-

-

-

Methodology and policy

640

267

-

-

907

Foreign exchange movements1

(2,582)

(1,161)

(294)

-

(4,037)

Total RWA movements

(1,306)

429

2,757

50

1,930

Closing RWAs (as at 31.03.23)

212,567

42,425

39,591

43,865

338,448

 

1

Foreign exchange movements does not include the impact of foreign exchange for modelled market risk or operational risk.

 

Overall RWAs increased £1.9bn to £338.4bn (December 2022: £336.5bn)

Credit risk RWAs decreased £1.3bn:

·

A £1.1bn decrease in book size primarily driven by business activities within CIB

·

A £1.0bn increase in book quality RWAs driven by an increase in mortgages due to HPI refresh and a deterioration in credit quality within CIB

·

A £2.6bn decrease in FX primarily due to the depreciation of period end USD against GBP

Counterparty Credit risk RWAs increased £0.4bn:

·

A £1.2bn increase in book size primarily due to an increase in SFT client and trading activity within Global Markets

·

A £1.2bn decrease in FX primarily due to the depreciation of period end USD against GBP

Market risk RWAs increased £2.8bn:

·

A £3.1bn increase in book size primarily due to increased client and trading activity within Global Markets

 

Leverage ratios1,2

As at 31.03.23

As at 31.12.22

£m

£m

Average UK leverage ratio

4.8%

4.8%

Average T1 capital

59,488

60,865

Average UK leverage exposure

1,251,286

1,280,972

UK leverage ratio

5.1%

5.3%

CET1 capital

45,985

46,878

AT1 capital

13,724

13,224

T1 capital

59,709

60,102

UK leverage exposure

1,168,899

1,129,973

UK leverage exposure

Accounting assets

Derivative financial instruments

257,439

302,380

Derivative cash collateral

64,899

69,048

Securities financing transactions (SFT)

229,182

189,637

Loans and advances and other assets

987,530

952,634

Total IFRS assets

1,539,050

1,513,699

Regulatory consolidation adjustments

(6,998)

(8,278)

Derivatives adjustments

Derivatives netting

(217,312)

(256,309)

Adjustments to collateral

(50,131)

(52,715)

Net written credit protection

18,354

16,190

Potential future exposure (PFE) on derivatives

85,893

84,168

Total derivatives adjustments

(163,196)

(208,666)

SFT adjustments

25,787

24,203

Regulatory deductions and other adjustments

(21,984)

(21,447)

Weighted off-balance sheet commitments

120,754

124,169

Qualifying central bank claims

(280,346)

(272,321)

Settlement netting

(44,168)

(21,386)

UK leverage exposure

1,168,899

1,129,973

 

1

Capital and leverage measures are calculated applying the transitional arrangements of the CRR as amended by CRR II.

2

Fully loaded average UK leverage ratio was 4.7%, with £59.2bn of T1 capital and £1,251.0bn of leverage exposure. Fully loaded UK leverage ratio was 5.1%, with £59.5bn of T1 capital and £1,168.7bn of leverage exposure. Fully loaded UK leverage ratios are calculated without applying the transitional arrangements of the CRR as amended by CRR II.

 

The UK leverage ratio decreased to 5.1% (December 2022: 5.3%) primarily due to a £38.9bn increase in the leverage exposure and a £0.4bn decrease in Tier 1 capital. The UK leverage exposure increased to £1,168.9bn (December 2022: £1,130.0bn) largely due to an increase in SFT client and trading activity within Global Markets.

 

The average UK leverage ratio remained at 4.8% (December 2022: 4.8%) primarily due to a decrease in the average T1 capital offset by a decrease in the average leverage exposure of £29.7bn to £1,251.3bn, largely due to a reduction in derivatives as well as lower daily average SFT activity in the quarter, compared to Q4 2022.

 

MREL

MREL requirements including buffers1,2

Total requirement (£m) based on

Requirement as a percentage of:

As at 31.03.23

As at 31.12.22

As at 31.03.23

As at 31.12.22

Requirement based on RWAs (minimum requirement)

98,167

97,387

29.0%

28.9%

Requirement based on UK leverage exposure

94,012

91,213

8.0%

8.1%

Own funds and eligible liabilities2

As at 31.03.23

As at 31.12.22

£m

£m

CET1 capital

45,985

46,878

AT1 capital instruments and related share premium accounts3

13,724

13,224

T2 capital instruments and related share premium accounts3

7,444

8,875

Eligible liabilities

43,489

43,851

Total Barclays PLC (the Parent company) own funds and eligible liabilities

110,642

112,828

Total RWAs

338,448

336,518

Total UK leverage exposure

1,168,899

1,129,973

Own funds and eligible liabilities ratios as a percentage of:

As at 31.03.23

As at 31.12.22

Total RWAs

32.7%

33.5%

Total UK leverage exposure

9.5%

10.0%

 

As at 31 March 2023, Barclays PLC (the Parent company) held £110.6bn of own funds and eligible liabilities equating to 32.7% of RWAs. This was in excess of the Group's MREL requirement, excluding the PRA buffer, to hold £98.2bn of own funds and eligible liabilities equating to 29% of RWAs. The Group remains above its MREL regulatory requirement including the PRA buffer.

 

1

Minimum requirement excludes the confidential institution-specific PRA buffer.

2

CET1, T1 and T2 capital, and RWAs are calculated applying the transitional arrangements of the CRR as amended by CRR II. This includes IFRS 9 transitional arrangements and the grandfathering of CRR II non-compliant capital instruments.

3

Includes other AT1 capital regulatory adjustments and deductions of £60m (December 2022: £60m), and other T2 credit risk adjustments and deductions of £94m (December 2022: £125m).

 

Condensed Consolidated Financial Statements

 

Condensed consolidated income statement (unaudited)

Three months ended 31.03.23

Three months ended 31.03.22

£m

£m

Total income

7,237

6,496

Operating expenses excluding litigation and conduct

(4,111)

(3,588)

Litigation and conduct

1

(523)

Operating expenses

(4,110)

(4,111)

Other net expenses

(5)

(10)

Profit before impairment

3,122

2,375

Credit impairment charges

(524)

(141)

Profit before tax

2,598

2,234

Tax charge

(561)

(614)

Profit after tax

2,037

1,620

Attributable to:

Equity holders of the parent

1,783

1,404

Other equity instrument holders

246

215

Total equity holders of the parent

2,029

1,619

Non-controlling interests

8

1

Profit after tax

2,037

1,620

Earnings per share

p

p

Basic earnings per ordinary share

11.3

8.4

 

Condensed consolidated balance sheet (unaudited)

As at 31.03.23

As at 31.12.22

Assets

£m

£m

Cash and balances at central banks

265,874

256,351

Cash collateral and settlement balances

129,622

112,597

Loans and advances at amortised cost

403,548

398,779

Reverse repurchase agreements and other similar secured lending

771

776

Trading portfolio assets

137,857

133,813

Financial assets at fair value through the income statement

247,965

213,568

Derivative financial instruments

257,439

302,380

Financial assets at fair value through other comprehensive income

66,361

65,062

Investments in associates and joint ventures

912

922

Goodwill and intangible assets

8,664

8,239

Current tax assets

310

385

Deferred tax assets

6,489

6,991

Other assets

13,238

13,836

Total assets

1,539,050

1,513,699

Liabilities

Deposits at amortised cost

555,724

545,782

Cash collateral and settlement balances

117,234

96,927

Repurchase agreements and other similar secured borrowing

28,386

27,052

Debt securities in issue

116,647

112,881

Subordinated Liabilities

10,072

11,423

Trading portfolio liabilities

90,079

72,924

Financial liabilities designated at fair value

289,428

271,637

Derivative financial instruments

247,167

289,620

Current tax liabilities

562

580

Deferred tax liabilities

17

16

Other liabilities

13,079

15,597

Total liabilities

1,468,395

1,444,439

Equity

Called up share capital and share premium

4,344

4,373

Other reserves

(1,993)

(2,192)

Retained earnings

53,564

52,827

Shareholders' equity attributable to ordinary shareholders of the parent

55,915

55,008

Other equity instruments

13,784

13,284

Total equity excluding non-controlling interests

69,699

68,292

Non-controlling interests

956

968

Total equity

70,655

69,260

Total liabilities and equity

1,539,050

1,513,699

 

Condensed consolidated statement of changes in equity (unaudited)

Called up share capital and share premium

Other equity instruments

Other reserves

Retained earnings

Total

Non-controlling interests

Total equity

Three months ended 31.03.2023

£m

£m

£m

£m

£m

£m

£m

Balance as at 1 January 2023

4,373

13,284

(2,192)

52,827

68,292

968

69,260

Profit after tax

-

246

-

1,783

2,029

8

2,037

Retirement benefit remeasurements

-

-

-

135

135

-

135

Other comprehensive profit after tax for the year

-

-

151

-

151

-

151

Total comprehensive income for the period

-

246

151

1,918

2,315

8

2,323

Employee share schemes and hedging thereof

16

-

-

356

372

-

372

Issue and redemption of other equity instruments

-

500

-

(5)

495

-

495

Other equity instruments coupon paid

-

(246)

-

-

(246)

-

(246)

Vesting of employee share schemes

-

-

3

(470)

(467)

-

(467)

Dividends paid

-

-

-

(793)

(793)

(8)

(801)

Repurchase of shares

(45)

-

45

(276)

(276)

-

(276)

Other movements

-

-

-

7

7

(12)

(5)

Balance as at 31 March 2023

4,344

13,784

(1,993)

53,564

69,699

956

70,655

 

Other reserves

As at 31.03.23

As at 31.12.22

£m

£m

Currency translation reserve

4,241

4,772

Fair value through other comprehensive income reserve

(1,411)

(1,560)

Cash flow hedging reserve

(6,162)

(7,235)

Own credit reserve

(73)

467

Other reserves and treasury shares

1,412

1,364

Total

(1,993)

(2,192)

 

 

The Group's management believes that the non-IFRS performance measures included in this document provide valuable information to the readers of the financial statements as they enable the reader to identify a more consistent basis for comparing the businesses' performance between financial periods, and provide more detail concerning the elements of performance which the managers of these businesses are most directly able to influence or are relevant for an assessment of the Group. They also reflect an important aspect of the way in which operating targets are defined and performance is monitored by management.

 

However, any non-IFRS performance measures in this document are not a substitute for IFRS measures and readers should consider the IFRS measures as well.

 

Appendix: Non-IFRS Performance Measures

 

Non-IFRS performance measures glossary

 

Measure

Definition

Loan: deposit ratio

Loans and advances at amortised cost divided by deposits at amortised cost.

Period end allocated tangible equity

Allocated tangible equity is calculated as 13.5% (2022: 13.5%) of RWAs for each business, adjusted for capital deductions, excluding goodwill and intangible assets, reflecting the assumptions the Group uses for capital planning purposes. Head Office allocated tangible equity represents the difference between the Group's tangible shareholders' equity and the amounts allocated to businesses.

Average tangible shareholders' equity

Calculated as the average of the previous month's period end tangible equity and the current month's period end tangible equity. The average tangible shareholders' equity for the period is the average of the monthly averages within that period.

Average allocated tangible equity

Calculated as the average of the previous month's period end allocated tangible equity and the current month's period end allocated tangible equity. The average allocated tangible equity for the period is the average of the monthly averages within that period.

Return on average tangible shareholders' equity

Annualised profit after tax attributable to ordinary equity holders of the parent, as a proportion of average shareholders' equity excluding non-controlling interests and other equity instruments adjusted for the deduction of intangible assets and goodwill. The components of the calculation have been included on pages 39 to 40.

Return on average allocated tangible equity

Annualised profit after tax attributable to ordinary equity holders of the parent, as a proportion of average allocated tangible equity. The components of the calculation have been included on pages 39 to 41.

Operating expenses excluding litigation and conduct

A measure of total operating expenses excluding litigation and conduct charges.

Operating costs

A measure of total operating expenses excluding litigation and conduct charges and UK bank levy.

Cost: income ratio

Total operating expenses divided by total income.

Loan loss rate

Quoted in basis points and represents total impairment charges divided by gross loans and advances held at amortised cost at the balance sheet date. The components of the calculation have been included on page 22.

Net interest margin

Annualised net interest income divided by the sum of average customer assets. The components of the calculation have been included on page 21.

Tangible net asset value per share

Calculated by dividing shareholders' equity, excluding non-controlling interests and other equity instruments, less goodwill and intangible assets, by the number of issued ordinary shares. The components of the calculation have been included on page 42.

Profit before impairment

Calculated by excluding credit impairment charges or releases from profit before tax.

 

Returns

 

Return on average tangible equity is calculated as profit after tax attributable to ordinary equity holders of the parent as a proportion of average tangible equity, excluding non-controlling and other equity interests for businesses. Allocated tangible equity has been calculated as 13.5% (2022: 13.5%) of RWAs for each business, adjusted for capital deductions, excluding goodwill and intangible assets, reflecting the assumptions the Group uses for capital planning purposes. Head Office average allocated tangible equity represents the difference between the Group's average tangible shareholders' equity and the amounts allocated to businesses.

 

Profit/(loss) attributable to ordinary equity holders of the parent

Average tangible equity

Return on average tangible equity

For the three months ended 31.03.23

£m

£bn

%

Barclays UK

515

10.3

20.0

Corporate and Investment Bank

1,209

31.8

15.2

Consumer, Cards and Payments

139

5.3

10.5

Barclays International

1,348

37.1

14.5

Head Office

(80)

0.2

n/m

Barclays Group

1,783

47.6

15.0

For the three months ended 31.03.22

Barclays UK

396

10.1

15.6

Corporate and Investment Bank

1,316

30.8

17.1

Consumer, Cards and Payments

(16)

4.3

(1.5)

Barclays International

1,300

35.1

14.8

Head Office

(292)

3.6

n/m

Barclays Group

1,404

48.8

11.5

 

Barclays Group

Return on average tangible shareholders' equity

Q123

Q422

Q322

Q222

Q122

Q4211

Q3211

Q2211

£m

£m

£m

£m

£m

£m

£m

£m

Attributable profit

1,783

1,036

1,512

1,071

1,404

1,079

1,374

2,048

£bn

£bn

£bn

£bn

£bn

£bn

£bn

£bn

Average shareholders' equity

55.9

54.9

56.8

57.1

56.9

56.1

56.5

54.4

Average goodwill and intangibles

(8.3)

(8.2)

(8.2)

(8.1)

(8.1)

(8.1)

(8.2)

(7.9)

Average tangible shareholders' equity

47.6

46.7

48.6

49.0

48.8

48.0

48.3

46.5

Return on average tangible shareholders' equity

15.0%

8.9%

12.5%

8.7%

11.5%

9.0%

11.4%

17.6%

 

Barclays UK

Return on average allocated tangible equity

Q123

Q422

Q322

Q222

Q122

Q421

Q321

Q221

£m

£m

£m

£m

£m

£m

£m

£m

Attributable profit

515

474

549

458

396

420

317

721

£bn

£bn

£bn

£bn

£bn

£bn

£bn

£bn

Average allocated equity

13.9

13.7

13.5

13.6

13.7

13.6

13.6

13.5

Average goodwill and intangibles

(3.6)

(3.5)

(3.6)

(3.6)

(3.6)

(3.6)

(3.6)

(3.6)

Average allocated tangible equity

10.3

10.2

9.9

10.0

10.1

10.0

10.0

9.9

Return on average allocated tangible equity

20.0%

18.7%

22.1%

18.4%

15.6%

16.8%

12.7%

29.1%

 

1

The comparative capital and financial metrics relating to Q221 - Q421 have been restated to reflect the impact of the Over-issuance of Securities.

 

Barclays International

Return on average allocated tangible equity

Q123

Q422

Q322

Q222

Q122

Q4211

Q3211

Q2211

£m

£m

£m

£m

£m

£m

£m

£m

Attributable profit

1,348

625

1,136

783

1,300

818

1,191

1,207

£bn

£bn

£bn

£bn

£bn

£bn

£bn

£bn

Average allocated equity

38.1

39.9

40.1

38.2

36.0

33.8

32.7

33.0

Average goodwill and intangibles

(1.0)

(1.0)

(1.0)

(0.9)

(0.9)

(0.9)

(0.9)

(0.6)

Average allocated tangible equity

37.1

38.9

39.1

37.3

35.1

32.9

31.8

32.4

Return on average allocated tangible equity

14.5%

6.4%

11.6%

8.4%

14.8%

9.9%

14.9%

14.9%

 

 

Corporate and Investment Bank

Return on average allocated tangible equity

Q123

Q422

Q322

Q222

Q122

Q4211

Q3211

Q2211

£m

£m

£m

£m

£m

£m

£m

£m

Attributable profit

1,209

454

1,015

579

1,316

695

1,085

989

£bn

£bn

£bn

£bn

£bn

£bn

£bn

£bn

Average allocated equity

31.8

33.7

34.0

32.7

30.8

28.7

27.8

28.4

Average goodwill and intangibles

-

-

-

-

-

-

-

-

Average allocated tangible equity

31.8

33.7

34.0

32.7

30.8

28.7

27.8

28.4

Return on average allocated tangible equity

15.2%

5.4%

11.9%

7.1%

17.1%

9.7%

15.6%

14.0%

 

Consumer, Cards and Payments

Return on average allocated tangible equity

Q123

Q422

Q322

Q222

Q122

Q421

Q321

Q221

£m

£m

£m

£m

£m

£m

£m

£m

Attributable profit/(loss)

139

171

121

204

(16)

123

106

218

£bn

£bn

£bn

£bn

£bn

£bn

£bn

£bn

Average allocated equity

6.3

6.2

6.1

5.5

5.2

5.1

4.9

4.6

Average goodwill and intangibles

(1.0)

(1.0)

(1.0)

(0.9)

(0.9)

(0.9)

(0.9)

(0.6)

Average allocated tangible equity

5.3

5.2

5.1

4.6

4.3

4.2

4.0

4.0

Return on average allocated tangible equity

10.5%

13.0%

9.5%

17.8%

(1.5)%

11.7%

10.5%

21.8%

 

1

The comparative capital and financial metrics relating to Q221 - Q421 have been restated to reflect the impact of the Over-issuance of Securities.

 

Tangible net asset value per share

As at 31.03.23

As at 31.12.22

As at 31.03.22

£m

£m

£m

Total equity excluding non-controlling interests

69,699

68,292

68,465

Other equity instruments

(13,784)

(13,284)

(11,119)

Goodwill and intangibles

(8,664)

(8,239)

(8,046)

Tangible shareholders' equity attributable to ordinary shareholders of the parent

47,251

46,769

49,300

m

m

m

Shares in issue

15,701

15,871

16,762

p

p

p

Tangible net asset value per share

301

295

294

 

Notable Items

Three months ended 31.03.23

Three months ended 31.03.22

£m

Profit before tax

Attributable profit

Profit before tax

Attributable profit

Statutory

2,598

1,783

2,234

1,404

Net impact from the Over-issuance of Securities

-

-

(320)

(240)

Customer remediation costs on legacy loan portfolio

-

-

(181)

(147)

Other litigation and conduct

1

2

(22)

(15)

Re-measurement of UK DTAs

-

-

-

(346)

Excluding the impact of notable items

2,597

1,781

2,757

2,152

 

The Group's management believes that the non-IFRS performance measures excluding notable items, included in the table above, provide valuable information to enable users of the financial statements to assess the performance of the Group. The notable items are separately identified within the Group's results disclosures which, when excluded from Barclays' statutory financials, provide an underlying profit and loss performance of the Group and enables consistent comparison of performance from one period to another.

 

These non-IFRS performance measures excluding notable items are included as a reference point only and are not incorporated within any of the key financial metrics used in our Group Targets, which are measured on a statutory basis.

 

Shareholder Information

 

Results timetable1

Date

2023 Interim Results Announcement

27 July 2023

% Change3

Exchange rates2

31.03.23

31.12.22

31.03.22

31.12.22

31.03.22

Period end - USD/GBP

1.23

1.21

1.31

2%

(6)%

3 month average - USD/GBP

1.22

1.17

1.34

4%

(9)%

Period end - EUR/GBP

1.14

1.13

1.19

1%

(4)%

3 month average - EUR/GBP

1.13

1.15

1.20

(2)%

(6)%

Share price data

Barclays PLC (p)

145.80

158.52

148.30

Barclays PLC number of shares (m)4

15,701

15,871

16,762

For further information please contact

Investor relations

Media relations

Adam Strachan +1 212 526 8442

Tom Hoskin +44 (0) 20 7116 4755

James Johnson +44 (0) 20 7116 7233

More information on Barclays can be found on our website: home.barclays

Registered office

1 Churchill Place, London, E14 5HP, United Kingdom. Tel: +44 (0) 20 7116 1000. Company number: 48839.

Registrar

Equiniti, Aspect House, Spencer Road, Lancing, West Sussex, BN99 6DA, United Kingdom.

Tel: 0371 384 20555 from the UK or +44 121 415 7004 from overseas.

American Depositary Receipts (ADRs)

EQ Shareowner Services

P.O. Box 64504

St. Paul, MN 55164-0504

United States of America

shareowneronline.com

Toll Free Number: +1 800-990-1135

Outside the US +1 651-453-2128

Delivery of ADR certificates and overnight mail

EQ Shareowner Services, 1110 Centre Pointe Curve, Suite 101, Mendota Heights, MN 55120-4100, USA.

 

1

Note that these dates are provisional and subject to change.

2

The average rates shown above are derived from daily spot rates during the year.

3

The change is the impact to GBP reported information.

4

The number of shares of 15,701m as at 31 March is different from the 15,688m quoted in the 3 April 2023 announcement because the share buyback transactions executed on 30 and 31 March 2023 did not settle until 3 April 2023 and 4 April 2023 respectively.

5

Lines open 8.30am to 5.30pm (UK time), Monday to Friday, excluding UK public holidays in England and Wales.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRFUNVBROAUSUAR
Date   Source Headline
1st May 20247:30 amRNSTransaction in Own Shares
30th Apr 20244:35 pmRNSDirector/PDMR Shareholding
30th Apr 20242:30 pmRNSForm 8.3 - Wincanton plc
30th Apr 20242:29 pmRNSForm 8.3 - Virgin Money UK plc
30th Apr 20242:26 pmRNSForm 8.3 - UK Commercial Property REIT Limited
30th Apr 20242:26 pmRNSForm 8.3 - Tyman plc
30th Apr 20242:24 pmRNSForm 8.3 - Tritax Big Box REIT plc
30th Apr 20242:22 pmRNSForm 8.3 - Spirent Communications plc
30th Apr 20242:21 pmRNSForm 8.3 - Quanex Building Products Corporation
30th Apr 20242:19 pmRNSForm 8.3 - Network International Holdings plc
30th Apr 20242:17 pmRNSForm 8.3 - Mattioli Woods plc
30th Apr 20242:17 pmRNSForm 8.3 - Lok’n Store Group plc
30th Apr 20242:15 pmRNSForm 8.3 - International Paper Company
30th Apr 20242:11 pmRNSForm 8.3 - Smith (DS) plc
30th Apr 20242:08 pmRNSForm 8.3 - Darktrace plc
30th Apr 202411:59 amRNSForm 8.5 (EPT/NON-RI)REDROW PLC
30th Apr 202411:58 amRNSForm 8.5 (EPT/NON-RI) BHP GROUP LTD
30th Apr 202411:58 amRNSForm 8.5 (EPT/NON-RI) BARRATT DEVELOPMENTS PLC
30th Apr 202411:58 amRNSForm 8.5 (EPT/NON-RI)ANGLO AMERICAN PLC
30th Apr 202411:57 amRNSForm 8.5 (EPT/NON-RI)BALANCED COMMERCIAL PROP TRUS
30th Apr 202411:57 amRNSForm 8.5 (EPT/NON-RI)INTERNATIONAL DISTRIBUTI SERV
30th Apr 202411:56 amRNSForm 38.5(b)-Irish Residential Properties REIT plc
30th Apr 20247:30 amRNSTransaction in Own Shares
29th Apr 20244:35 pmRNSDirector/PDMR Shareholding
29th Apr 20241:08 pmRNSForm 8.3 - Wincanton plc
29th Apr 20241:07 pmRNSForm 8.3 - Virgin Money UK plc
29th Apr 20241:01 pmRNSForm 8.3 - UK Commercial Property REIT Limited
29th Apr 202412:59 pmRNSForm 8.3 - Tritax Big Box REIT plc
29th Apr 202412:57 pmRNSForm 8.3 - Spirent Communications plc
29th Apr 202412:55 pmRNSForm 8.3 - Tyman plc
29th Apr 202412:53 pmRNSForm 8.3 - Quanex Building Products Corporation
29th Apr 202412:51 pmRNSForm 8.3 - Network International Holdings plc
29th Apr 202412:50 pmRNSForm 8.3 - Mattioli Woods plc
29th Apr 202412:47 pmRNSForm 8.3 - Lok’n Store Group plc
29th Apr 202412:44 pmRNSForm 8.3 - Kin and Carta plc
29th Apr 202412:41 pmRNSForm 8.3 - International Paper Company
29th Apr 202412:40 pmRNSForm 8.3 - Smith (DS) plc
29th Apr 202412:35 pmRNSForm 8.3 - Darktrace plc
29th Apr 202411:22 amRNSForm 38.5(b)-Irish Residential Properties REIT plc
29th Apr 202411:20 amRNSForm 8.5(EPT/NON-RI)-International Distribut Serv
29th Apr 202411:17 amRNSForm 8.5 (EPT/NON-RI) - Redrow plc
29th Apr 202411:16 amRNSForm 8.5 (EPT/NON-RI) - Barratt Developments plc
29th Apr 202411:12 amRNSForm 8.5 (EPT/NON-RI)-Balanced Commercial Prop Tru
29th Apr 202411:10 amRNSForm 8.5 (EPT/NON-RI) - BHP Group Limited
29th Apr 202411:08 amRNSForm 8.5 (EPT/NON-RI) - Anglo American plc
29th Apr 20247:30 amRNSTransaction in Own Shares
26th Apr 20246:15 pmRNSPublication of Suppl.Prospcts
26th Apr 20244:00 pmRNSPublication of a Prospectus
26th Apr 20243:03 pmRNSForm 8.3 - Wincanton plc
26th Apr 20243:02 pmRNSForm 8.3 - Virgin Money UK plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.